MD MSc PhD S.S. Gisbertz

foto

MD MSc PhD S.S. Gisbertz

Position
Medical Specialist
Main activities
Patient care, Research
Specialisation
Upper GI Surgery
Focus of research

There are 2 organ specifik reseach fields in oncologic upper GI surgery: research concerning the esophagus and research concerning the stomach.

 

My research focus in esophageal cancer

- Dissimination pattern of lymph node metastases and optimal extent of lymphadenectomy

- Optimal surgical approach in esophageal cancer surgery; transthoracic or transhiatal esophagectomy

- Quality of life after different esophageal cancer operations

- Postoperative morbidity: occurence and possible ways to reduce morbidity

- Fluorescence imaging and other imaging techniques to visualize perfusion

- Sentinel node surgery inearly esophageal cancer 

- Sarcopenia in esophageal cancer patients

 

My research focus in gastri cancer

- The value of omentectomy in gastric cancer surgery

- The value of diagnostic laparaoscopy in gastric cancer staging

- Quality of life after different surgical approaches for proximal gastric cancer 

Key publications
  • Hagens Eliza R. C., van Berge Henegouwen Mark I., van Sandick Johanna W., Cuesta Miguel A., van der Peet Donald L., Heisterkamp Joos, Nieuwenhuijzen Grard A. P., Rosman Camiel, Scheepers Joris J. G., Sosef Meindert N., van Hillegersberg Richard, Lagarde Sjoerd M., Nilsson Magnus, Räsänen Jari, Nafteux Philippe, Pattyn Piet, Hölscher Arnulf H., Schröder Wolfgang, Schneider Paul M., Mariette Christophe, Castoro Carlo, Bonavina Luigi, Rosati Riccardo, de Manzoni Giovanni, Mattioli Sandro, Garcia Josep Roig, Pera Manuel, Griffin Michael, Wilkerson Paul, Chaudry M. Asif, Sgromo Bruno, Tucker Olga, Cheong Edward, Moorthy Krishna, Walsh Thomas N., Reynolds John, Tachimori Yuji, Inoue Haruhiro, Matsubara Hisahiro, Kosugi Shin-Ichi, Chen Haiquan, Law Simon Y. K., Pramesh C. S., Puntambekar Shailesh P., Murthy Sudish, Linden Philip, Hofstetter Wayne L., Kuppusamy Madhan K., Shen K. Robert, Darling Gail E., Sabino Flávio D., Grimminger Peter P., Meijer Sybren L., Bergman Jacques J. G. H. M., Hulshof Maarten C. C. M., van Laarhoven Hanneke W. M., Mearadji Banafsche, Bennink Roel J., Annema Jouke T., Dijkgraaf Marcel G. W., Gisbertz Suzanne S. Distribution of lymph node metastases in esophageal carcinoma [TIGER study]: Study protocol of a multinational observational study BMC cancer 2019;19 (1) [PubMed]
  • van Rijswijk A. S., Hagens E. R. C., van der Peet D. L., van Berge Henegouwen M. I., Gisbertz S. S. Differences in Esophageal Cancer Surgery in Terms of Surgical Approach and Extent of Lymphadenectomy: Findings of an International Survey Annals of surgical oncology 2019;26 (7):2063-2072 [PubMed]
  • Jongerius E. J., Boerma D., Seldenrijk K. A., Meijer S. L., Scheepers J. J. G., Smedts F., Lagarde S. M., Balague Ponz O., van Berge Henegouwen M. I., van Sandick J. W., Gisbertz S. S. Role of omentectomy as part of radical surgery for gastric cancer British journal of surgery 2016;103 (11):1497-1503 [PubMed]
  • Jansen S. M., de Bruin D. M., van Berge Henegouwen M. I., Bloemen P. R., Strackee S. D., Veelo D. P., van Leeuwen T. G., Gisbertz S. S. Effect of ephedrine on gastric conduit perfusion measured by laser speckle contrast imaging after esophagectomy: a prospective in vivo cohort study Diseases of the esophagus 2018;31 (10) [PubMed]
  • Hagens Eliza R. C., Anderegg Maarten C. J., van Berge Henegouwen Mark I., Gisbertz Suzanne S. International Survey on the Management of Anastomotic Leakage After Esophageal Resection Annals of thoracic surgery 2018;106 (6):1702-1708 [PubMed]
All Publications
Curriculum Vitae

Curriculum Vitae

 

Personal details

Name                                     Gisbertz, Suzanne Sarah

Address                                  Haparandaweg 898

Postal code/city                      1013 BD Amsterdam

Telephone                              +31621225908

Email                                      s.s.gisbertz@amc.nl

Nationality                             Dutch

Date of birth                           April 29, 1974

Place of birth                          Breda, the Netherlands

 

Education & medical training

2012                                       Fellow (advanced surgical training) bariatric and gastrointestinal surgery, Sint Antonius Ziekenhuis Nieuwegein (Dr. D Boerma).

2010-2012                              CHIVO (advanced surgical training) gastro-intestinal surgery, VUmc Amsterdam (Prof.dr. MA Cuesta).

2004-2010                              Surgical training (resident), UMC Utrecht and Sint Antonius Ziekenhuis Nieuwegein (Prof.dr. IHM Borel Rinkes, Dr. PMNYH Go). Differentiation gastro-intestinal surgery (Dr. B van Ramshorst).

2002-2003                              Surgical resident, OLVG, Amsterdam.

2000-2002                              MD, Medical school, University of Amsterdam.

1993-2000                              Master’s degree, University of Amsterdam.

1992-1993                              College preparatory high school education, Teisterbandcollege Zeist.

 

Doctorate

16-12-2009                             Remote endarterectomy for arterial occlusive disease. Determinants for success. Supervisors: Prof.dr. FL Moll, Prof.dr. G Pasterkamp. Co-supervisors: Dr. JPPM de Vries, Dr. GJ de Borst. University of Utrecht.

 

Work since completion of medical training

2013 -                                     Gastro-intestinal & oncological surgeon (upper-GI) AMC, Amsterdam.

2012 - 2014                            Procurator for thoracolaparoscopic esophageal resections and laparoscopic gastrectomies in Reinier de Graaf Gasthuis Delft, Sint Antonius Ziekenhuis Nieuwegein and Onze Lieve Vrouwen Gasthuis Amsterdam.

 

Organisation

2010 -                                     NVEC congress organisation: organisation of foreign conferences and workshops.

2015 -                                     ISDE Guidelines Committee esophageal diseases.

2015 -                                     European Think Tank for minimally invasive esophagectomy – development of European training centers and research programs.

2015 -                                     Workgroup for European research on esophageal cancer treatment.

2015 -                                     Dutch guideline committee Gastric Cancer.

2016 -                                     OESO Permanent Scientific Committee. Section of Endoscopic Surgery.

2016 -                                     Founding member of EGCA (European Gastric Cancer Association).

2016 -                                     Editorial board member Journal of Gastric Cancer.

2016 -                                     Congress organisation committee NVGIC theme year 2017.

2018 -                                     Manager of gastro-intestinal ward AMC

 

Memberships

The Association of Surgeons of the Netherlands (NVvH)

Dutch Society for Surgical Oncology (NVCO)

Dutch Society for Gastro-intestinal Surgery (NVGIC)

Dutch Society of Gastroenterology (NVGE)

International Society for Esophageal Diseases (ISDE)

European Society for Esophageal Diseases (ESDE)

International Gastric Cancer Asociation (IGCA)

Dutch upper-GI work group

 

Other activities

2008-2011                              Lead singer in surgery band.

1997-2006                              Professional show ballet dancer for different companies with national and international performances (USA, Ukraine, Israel, Germany, Belgium).

1998-2008                              Dive instructor for different dive schools in Thailand, Indonesia and the Netherlands.

1998-1999                              Journey around the world.

Sports                                     Track and field (Bronze medal Dutch Student Championships, 1997 4x100m relay), snowboarding/skiing, cycling (Les Trois Ballons 2014, La Marmotte 2014, Drieländergiro 2016, Maratona dles Dolomites 2016), wave surfing, diving, running (New York City Marathon 2014 in 03:56 hrs, Paris Marathon 2016).

 

Obtained Grants & Funds

2011                                       Dutch Society of Gastrointestinal Surgery travel grant (€ 2.500,-; Prof Inoue, Showa University Medical Center, Yokohama, Japan).

2014                                       Crowd funding by running the Marathon of New York City (€ 12.000,-;for the TIGER study).

2016                                       SLMK funding (€ 200.000)

2016                                       Egbers stichting funding (€ 75.000)

2017                                       Olympus Grant (€ 45.000)

2017                                       MLDS Grant (€ 250.000)

 

Reviewer

Congresses

2014 -                                     Reviewer abstracts United European Gastroenterology Week

Journals

Reviewer for the Journal of the American College of Surgeons, Diseases of the Esophagus, European Journal of Surgical Oncology, Annals of Surgery, World Journal of Surgical Oncology, Annals of Surgical Oncology, British Journal of Surgery, Gastric Cancer, Surgical Endoscopy, World Journal of Surgery, BMC cancer, Gastroenterology, Journal of Cancer, Journal of Thoracic Disease, Nederlands Tijdschrift voor Geneeskunde,

 

Thesis reading committee

2013                                       KW Maas, Minimally invasive esophagectomy for cancer: beyond techniques, VUmc, 12-02-2013.

2017                                       WAA Borstlap, New Insights in rectal cancer treatment, AMC, 03-11-2017.

2018                                       YHM Claassen, Quality Assurance in the Surgical Treatment of Gastric Cancer, LUMC, 11-12-2018.

2019                                       J van Hilst, Minimally Invasive Pancreatic Surgery: Introduction, Development and Outcome Assesment, AMC, 01-02-2019.

 

Primary / secondary research mentor PhD student

2013 – 2018                           MCJ Anderegg. Optimization of Ttreatment Strategies and Prognostication for Patients with Esophageal Cancer. PhD date 28-06-2018.

2014 -                                     AE Slaman, Complication Management after Esophageal Cancer Surgery.

2014 - 2018                            SM Jansen, Optical Perfusion Diagnostics in Esophageal Cancer Surgery. PhD date 29-11-2018.

2018 -                                     ERC Hagens, Lymph node metastases in Esophageal Cancer [TIGER study].

2018 -                                     MC Kalff. Ivor Lewis or McKeown (Transthoracic) versus Orringer (Transhiatal) Esophagectomy for Cancer of the Distal Esophagus or Gastro-Esophageal Junction [IVORY trial].

2018 -                                     ABJ Borgstein. Surgical Treatment of Gastric Cancer.

2018 -                                     E Jezerskyte. Quality of Life following Esophageal Surgery for Cancer.

 

Primary research mentor Medical Student

2013 -2015                             W.A.A. Borstlap, Distribution of Lymph Node Metastases in Esophageal Carcinoma: a systematic review.

2013 - 2016                            E.J. Jongerius, Omentectomy in Radical Gastrectomy for Gastric Cancer Trial [OMEGA trial], results of laparoscopic gastrectomy.

2014 - 2016                            A.S. Rijswijk, Distribution of Lymph Node Metastases in Esophageal Carcinoma [TIGER study].

 

Teaching

2017 -                                     Mentorship for medical interns, AMC, Amsterdam

2014 -                                     Moderator of the weekly medical students case presentations (‘revue’), AMC, Amsterdam.

2013 -                                     Small scale clinical case education (‘KKLO’), AMC, Amsterdam.

2013 -                                     Examiner clinical skills medical students, AMC Amsterdam.

2013 -                                     Physical examination of the abdomen for medical students, AMC, Amsterdam.

2013 -                                     Clinical lectures for medical students, AMC, Amsterdam.

2013 -                                     Laparoscopic skills training in animal lab (porcine model) for surgical residents, AMC, Amsterdam.

2013 -                                     Primary teacher of the physician assistant and the specialist nurse, AMC, Amsterdam.

2011 -                                     Faculty member of the national laparoscopic skills course (‘OCEH’) for Dutch surgical residents, Paris, France.

 

Research projects (last 5 years)

  • OMEGA trial; Omentectomy in Radical Gastrectomy for Gastric Cancer Trial; prospective multicenter cohort trial in 100 patients (4 centers). Status: Manuscript published in BJS, protocol for RCT applied for funding. Abstract presented during IGCC 2015, Sao Paulo, Brazil and several other international and national congresses.

 

  • IVORY trial; Ivor Lewis or McKeown versus Orringer esophagectomy for cancer of the distal esophagus or gastro-esophageal junction. A national SNAP SHOT study. Status: Including.

 

  • TIGER study; Distribution of lymph node metastases in esophageal carcinoma. A multicenter, multinational observational study. Status: Protocol writing finished, international collaboration meeting in Singapore, ISDE, September 2016, web-based CRF and database have been developed. Status: Including

 

  • IMPEC study: Impact of body composition, nutritional status and physical fitness on outcomes following surgery for esophageal cancer. Status: Funding proposed, retrospective study submitted.

 

  • Quality of life following esophagectomy and gastrectomy. Status: first paper submitted, several abstracts presented at UEGW 2015, ESDE 2015, ISDE 2016, ESDE 2017, ISDE 2018.

 

  • Microcirculation; Different techniques (laser speckle, dark-field imaging, OCT, fluorescence) to test the microcirculation at the side of the esophago-gastrostomy during esophagectomy for esophageal cancer. A prospective trial. Status: several papers published, new study started including patients. Abstracts presented at several international congresses, among others during the ISDE 016 in Singapore. Papers published in different journals.

 

  • CT and CRP; The value of CRP and CT-scanning in the detection of complications following major abdominal surgery and specifically Upper GI surgery. A retrospective analysis in 250 patients. Status: Manuscript published, second manuscript in writing phase

 

  • ORACLE trial; Lymphadenectomy without esophagectomy for early esophageal carcinoma. A feasibility study in cadaver, a porcine model and patients. Status: Article published in Dis Esoph.

 

  • SNAP study: Sentinel node biopsy in esophageal cancer surgery. A feasibility study. Status: First paper published second trial analysing results.

 

  • GOOSE trial: RCT of pylorodilation versus sham for pylorospasm after esophageal surgery. Status: Manuscript submitted.

 

  • TIME trial; Open versus minimally invasive esophagectomy for cancer; a multicenter randomized controlled trial. Status: Manuscript published in the Lancet.

 

  • Lymph node metastases in esophageal carcinoma; a systematic review. Status: Article writing phase.

 

  • MRI; MRI for staging of esophageal carcinoma. A feasibility study. Status: Protocol with METC.

 

  • PET-CT in the follow-up for esophageal carcinoma; A prospective trial. Status: Applied for funding.

 

  • TOR study; Long course chemoradiation followed by surgery for T4b esophageal carcinoma. Status: Manuscript published.

 

  • STOMACH trial; Laparoscopic versus open gastrectomy for gastric cancer. Status: Writing of manuscript, abstract presented at IGCC 2019.

 

 

Publications and lectures

Pubmed listed publications                   94

H-Index                                                  17

Book chapters                                        17

Invited lectures                                      >50

Abstracts                                                >150

 

Publications

  1. van den Ende T, Abe Nijenhuis FA, van den Boorn HG, Ter Veer E, Hulshof MCCM, Gisbertz SS, van Oijen MGH, van Laarhoven HWM. COMplot, A Graphical Presentation of Complication Profiles and Adverse Effects for the Curative Treatment of Gastric Cancer: A Systematic Review and Meta-Analysis. Front Oncol. 2019 Jul 25;9:684.
  2. Verboom DM, Koster-Brouwer ME, Ruurda JP, van Hillegersberg R, van Berge Henegouwen MI, Gisbertz SS, Scicluna BP, Bonten MJM, Cremer OL; MARS consortium. A pilot study of a novel molecular host response assay to diagnose infection in patients after high-risk gastro-intestinal surgery. J Crit Care. 2019 Jul 30;54:83-87. doi: 10.1016/j.jcrc.2019.07.020.
  3. Hagens ERC, van Berge Henegouwen MI, van Sandick JW, Cuesta MA, van der Peet DL, Heisterkamp J, Nieuwenhuijzen GAP, Rosman C, Scheepers JJG, Sosef MN, van Hillegersberg R, Lagarde SM, Nilsson M, Räsänen J, Nafteux P, Pattyn P, Hölscher AH, Schröder W, Schneider PM, Mariette C, Castoro C, Bonavina L, Rosati R, de Manzoni G, Mattioli S, Garcia JR, Pera M, Griffin M, Wilkerson P, Chaudry MA, Sgromo B, Tucker O, Cheong E, Moorthy K, Walsh TN, Reynolds J, Tachimori Y, Inoue H, Matsubara H, Kosugi SI, Chen H, Law SYK, Pramesh CS, Puntambekar SP, Murthy S, Linden P, Hofstetter WL, Kuppusamy MK, Shen KR, Darling GE, Sabino FD, Grimminger PP, Meijer SL, Bergman JJGHM, Hulshof MCCM, van Laarhoven HWM, Mearadji B, Bennink RJ, Annema JT, Dijkgraaf MGW, Gisbertz SS. Distribution of lymph node metastases in esophageal carcinoma [TIGER study]: study protocol of a multinational observational study. BMC Cancer. 2019 Jul 4;19(1):662. doi: 10.1186/s12885-019-5761-7.
  4. Cardiorespiratory Comorbidity and Postoperative Complications following Esophagectomy: a European Multicenter Cohort Study. Klevebro F, Elliott JA, Slaman A, Vermeulen BD, Kamiya S, Rosman C, Gisbertz SS, Boshier PR, Reynolds JV, Rouvelas I, Hanna GB, van Berge Henegouwen MI, Markar SR. Ann Surg Oncol. 2019 Jun 10. doi: 10.1245/s10434-019-07478-6.
  5. Prasetya H, Jansen SM, Marquering HA, van Leeuwen TG, Gisbertz SS, de Bruin DM, van Bavel E. Estimation of microvascular perfusion after esophagectomy: a quantitative model of dynamic fluorescence imaging. Med Biol Eng Comput. 2019 Jun 26. doi: 10.1007/s11517-019-01994-z.
  6. Hartmann's procedure versus sigmoidectomy with primary anastomosis for perforated diverticulitis with purulent or faecal peritonitis (LADIES): a multicentre, parallel-group, randomised, open-label, superiority trial. Lambrichts DPV, Vennix S, Musters GD, Mulder IM, Swank HA, Hoofwijk AGM, Belgers EHJ, Stockmann HBAC, Eijsbouts QAJ, Gerhards MF, van Wagensveld BA, van Geloven AAW, Crolla RMPH, Nienhuijs SW, Govaert MJPM, di Saverio S, D'Hoore AJL, Consten ECJ, van Grevenstein WMU, Pierik REGJM, Kruyt PM, van der Hoeven JAB, Steup WH, Catena F, Konsten JLM, Vermeulen J, van Dieren S, Bemelman WA, Lange JF; LADIES trial collaborators. Lancet Gastroenterol Hepatol. 2019 Jun 6. pii: S2468-1253(19)30174-8. doi: 10.1016/S2468-1253(19)30174-8.
  7. Fluorescent imaging using indocyanine green during esophagectomy to prevent surgical morbidity: a systematic review and meta-analysis. Slooter MD, Eshuis WJ, Cuesta MA, Gisbertz SS, van Berge Henegouwen MI. J Thorac Dis. 2019 Apr;11(Suppl 5):S755-S765. doi: 10.21037/jtd.2019.01.30.
  8. Optimal mobilization of the stomach and the best place in the gastric tube for intrathoracic anastomosis. Laméris W, Eshuis WJ, Cuesta MA, Gisbertz SS, van Berge Henegouwen MI. J Thorac Dis. 2019 Apr;11(Suppl 5):S743-S749. doi: 10.21037/jtd.2019.01.28. Review.
  9. On-demand versus continuous rocuronium infusion for deep neuromuscular relaxation in patients undergoing thoraco-laparoscopic esophagectomy: a randomized-controlled clinical trial (DEPTH). Veelo DP, Gisbertz SS, Binnekade JM, Hannivoort RA, Bosman JA, Geerts BF, Blobner M, van Berge Henegouwen MI, Hollmann MW. Can J Anaesth. 2019 Apr 25. doi: 10.1007/s12630-019-01373-0.
  10. Differences in Esophageal Cancer Surgery in Terms of Surgical Approach and Extent of Lymphadenectomy: Findings of an International Survey. van Rijswijk AS, Hagens ERC, van der Peet DL, van Berge Henegouwen MI, Gisbertz SS. Ann Surg Oncol. 2019 Jul;26(7):2063-2072. doi: 10.1245/s10434-019-07316-9.
  11. Nationwide Outcome of Gastrectomy with En-Bloc Partial Pancreatectomy for Gastric Cancer. van der Werf LR, Eshuis WJ, Draaisma WA, van Etten B, Gisbertz SS, van der Harst E, Liem MSL, Lemmens VEPP, Wijnhoven BPL, Besselink MG, van Berge Henegouwen MI; Dutch Upper Gastrointestinal Cancer Audit (DUCA) group. J Gastrointest Surg. 2019 Feb 28. doi: 10.1007/s11605-019-04133-z.
  12. Ebbing EA, van der Zalm AP, Steins A, Creemers A, Hermsen S, Rentenaar R, Klein M, Waasdorp C, Hooijer GKJ, Meijer SL, Krishnadath KK, Punt CJA, van Berge Henegouwen MI, Gisbertz SS, van Delden OM, Hulshof MCCM, Medema JP, van Laarhoven HWM, Bijlsma MF. Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma. Proc Natl Acad Sci U S A. 2019 Feb 5;116(6):2237-2242. doi: 10.1073/pnas.1820459116. Epub 2019 Jan 22.
  13. van den Ende T, Ter Veer E, Machiels M, Mali RMA, Abe Nijenhuis FA, de Waal L, Laarman M, Gisbertz SS, Hulshof MCCM, van Oijen MGH, van Laarhoven HWM. The Efficacy and Safety of (Neo)Adjuvant Therapy for Gastric Cancer: A Network Meta-analysis. Cancers (Basel). 2019 Jan 11;11(1). pii: E80. doi: 10.3390/cancers11010080.
  14. Belghazi K, Schölvinck DW, van Berge Henegouwen MI, Gisbertz SS, Weusten BL, Meijer SL, Bergman JJ, Pouw RE. Results of a two-phased clinical study evaluating a new multiband mucosectomy device for early Barrett's neoplasia: a randomized pre-esophagectomy trial and a pilot therapeutic pilot study. Surg Endosc. 2018 Nov 19. doi: 10.1007/s00464-018-6582-5. [Epub ahead of print]
  15. Borggreve AS, Mook S, Verheij M, Mul VEM, Bergman JJ, Bartels-Rutten A, Ter Beek LC, Beets-Tan RGH, Bennink RJ, van Berge Henegouwen MI, Brosens LAA, Defize IL, van Dieren JM, Dijkstra H, van Hillegersberg R, Hulshof MC, van Laarhoven HWM, Lam MGEH, van Lier ALHMW, Muijs CT, Nagengast WB, Nederveen AJ, Noordzij W, Plukker JTM, van Rossum PSN, Ruurda JP, van Sandick JW, Weusten BLAM, Voncken FEM, Yakar D, Meijer GJ; PRIDE study group. Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study. BMC Cancer. 2018 Oct 20;18(1):1006. doi: 10.1186/s12885-018-4892-6.
  16. Saadeh LM, Slaman AE, Pinto E, Gisbertz SS, Cavallin F, Jezerskyte E, Alfieri R, Noteboom L, Bellissimo MC, Cagol M, Pirozzolo G, Castoro C, Scarpa M, van Berge Henegouwen MI. Esophageal cancer patients' information management: cross-cultural differences between Dutch and Italian patients in perceived quality of provided oncological information. J Thorac Dis. 2018 Aug;10(8):5123-5130.
  17. Fransen L, Berkelmans G, Asti E, Van Berge Henegouwen M, Berlth F, Bonavina L, Brown A, Bruns C, Gisbertz S, Grimminger P, Gutschow C, Hölscher A, Kauppi J, Lagarde SM, Mercer S, Moons J, Nafteux P, Nilsson M, Palazzo F, Pattyn P, Philippron A, Raptis D, Räsänen J, Rosato E, Rouvelas I, Schmidt H, Schneider P, Schröder W, Wijnhoven BPL, Grard AP, Nieuwenhuijzen, Luyer M. FA01.02: THE EFFECT OF POSTOPERATIVE COMPLICATIONS AFTER MIE ON LONG-TERM SURVIVAL: A RETROSPECTIVE, MULTI-CENTER COHORT STUDY. Dis Esophagus. 2018 Sep 1;31(13):1.
  18. Gisbertz SS, Hagens ERC, Ruurda JP, Schneider PM, Tan LJ, Domrachev SA, Hoeppner J, van Berge Henegouwen MI. The evolution of surgical approach for esophageal cancer. Ann N Y Acad Sci. 2018 Sep 7. doi: 10.1111/nyas.13957.
  19. van Putten M, Nelen SD, Lemmens VEPP, Stoot JHMB, Hartgrink HH, Gisbertz SS, Spillenaar Bilgen EJ, Heisterkamp J, Verhoeven RHA, Nieuwenhuijzen GAP. Overall survival before and after centralization of gastric cancer surgery in the Netherlands. Br J Surg. 2018 Aug 22.
  20. van Workum F, Slaman AE, van Berge Henegouwen MI, Gisbertz SS, Kouwenhoven EA, van Det MJ, van den Wildenberg FJH, Polat F, Luyer MDP, Nieuwenhuijzen GAP, Rosman C. Propensity Score-Matched Analysis Comparing Minimally Invasive Ivor Lewis Versus Minimally Invasive Mckeown Esophagectomy. Ann Surg. 2018 Aug 10.
  21. He H, Gruartmoner G, Ince Y, van Berge Henegouwen MI, Gisbertz SS, Geerts BF, Ince C, Hollmann MW, Liu D, Veelo DP. Effect of pneumoperitoneum and steep reverse-Trendelenburg position on mean systemic filling pressure, venous return, and microcirculation during esophagectomy. J Thorac Dis. 2018 Jun;10(6):3399-3408.
  22. Creemers A, Ebbing EA, Hooijer GKJ, Stap L, Jibodh-Mulder RA, Gisbertz SS, van Berge Henegouwen MI, van Montfoort ML, Hulshof MCCM, Krishnadath KK, van Oijen MGH, Bijlsma MF, Meijer SL, van Laarhoven HWM. The dynamics of HER2 status in esophageal adenocarcinoma. Oncotarget. 2018 Jun 1;9(42):26787-26799.
  23. Eshuis WJ, van Berge Henegouwen MI, Draaisma WA, Gisbertz SS. Compliance to D2 lymphadenectomy in laparoscopic gastrectomy. Updates Surg. 2018 Jun 20.
  24. Mari L, Hoefnagel SJM, Zito D, van de Meent M, van Endert P, Calpe S, Sancho Serra MDC, Heemskerk MHM, van Laarhoven HWM, Hulshof MCCM, Gisbertz SS, Medema JP, van Berge Henegouwen MI, Meijer SL, Bergman JJGHM, Milano F, Krishnadath KK. microRNA 125a Regulates MHC-I Expression on Esophageal Adenocarcinoma Cells, Associated With Suppression of Antitumor Immune Response and Poor Outcomes of Patients. Gastroenterology. 2018 Sep;155(3):784-798.
  25. Hagens ERC, Anderegg MCJ, van Berge Henegouwen MI, Gisbertz SS. International Survey on the Management of Anastomotic Leakage after Esophageal Resection. Ann Thorac Surg. 2018 Jun 5. pii: S0003-4975(18)30738-0.
  26. van Egmond MA, van der Schaaf M, Hagens ERC, van Laarhoven HWM, van Berge Henegouwen MI, Haverkort EB, Engelbert RHH, Gisbertz SS. Muscle Strength Is Associated With Muscle Mass in Patients With Esophageal Cancer Awaiting Surgery. J Geriatr Phys Ther. 2018 Jun 1.
  27. Cuesta MA, van der Peet DL, Gisbertz SS, Straatman J. Mediastinal lymphadenectomy for esophageal cancer: Differences between two countries, Japan and the Netherlands. Ann Gastroenterol Surg. 2018 May 1;2(3):176-181.
  28. Noordman BJ, Spaander MCW, Valkema R, Wijnhoven BPL, van Berge Henegouwen MI, Shapiro J, Biermann K, van der Gaast A, van Hillegersberg R, Hulshof MCCM, Krishnadath KK, Lagarde SM, Nieuwenhuijzen GAP, Oostenbrug LE, Siersema PD, Schoon EJ, Sosef MN, Steyerberg EW, van Lanschot JJB; SANO study group. Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study. Lancet Oncol. 2018 Jul;19(7):965-974.
  29. Baiocchi GL, Giacopuzzi S, Marrelli D, Reim D, Piessen G, Matos da Costa P, Reynolds JV, Meyer HJ, Morgagni P, Gockel I, Lara Santos L, Jensen LS, Murphy T, Preston SR, Ter-Ovanesov M, Fumagalli Romario U, Degiuli M, Kielan W, Mönig S, Kołodziejczyk P, Polkowski W, Hardwick R, Pera M, Johansson J, Schneider PM, de Steur WO, Gisbertz SS, Hartgrink H, van Sandick JW, Portolani N, Hölscher AH, Botticini M, Roviello F, Mariette C, Allum W, De Manzoni G. International consensus on a complications list after gastrectomy for cancer. Gastric Cancer. 2018 May 30.
  30. Lagarde SM, Anderegg MCJ, Gisbertz SS, Meijer SL, Hulshof MCCM, Bergman JJGHM, van Laarhoven HWM, van Berge Henegouwen MI. Lymph node metastases near the celiac trunk should be considered separately from other nodal metastases in patients with cancer of the esophagus or gastroesophageal junction after neoadjuvant treatment and surgery. J Thorac Dis. 2018 Mar;10(3):1511-1521.
  31. Jansen SM, de Bruin DM, van Berge Henegouwen MI, Strackee SD, Veelo DP, van Leeuwen TG, Gisbertz SS. Optical techniques for perfusion monitoring of the gastric tube after esophagectomy: a review of technologies and thresholds. Dis Esophagus. 2018 Jun 1;31(6).
  32. Jansen SM, Almasian M, Wilk LS, de Bruin DM, van Berge Henegouwen MI, Strackee SD, Bloemen PR, Meijer SL, Gisbertz SS, van Leeuwen TG. Feasibility of Optical Coherence Tomography (OCT) for Intra-Operative Detection of Blood Flow during Gastric Tube Reconstruction. Sensors (Basel). 2018 Apr 25;18(5). pii: E1331.
  33. Brenkman HJF, Gertsen EC, Vegt E, van Hillegersberg R, van Berge Henegouwen MI, Gisbertz SS, Luyer MDP, Nieuwenhuijzen GAP, van Lanschot JJB, Lagarde SM, de Steur WO, Hartgrink HH, Stoot JHMB, Hulsewe KWE, Spillenaar Bilgen EJ, van Det MJ, Kouwenhoven EA, van der Peet DL, Daams F, van Sandick JW, van Grieken NCT, Heisterkamp J, van Etten B, Haveman JW, Pierie JP, Jonker F, Thijssen AY, Belt EJT, van Duijvendijk P, Wassenaar E, van Laarhoven HWM, Wessels FJ, Haj Mohammad N, van Stel HF, Frederix GWJ, Siersema PD, Ruurda JP; PLASTIC Study Group. Evaluation of PET and laparoscopy in STagIng advanced gastric cancer: a multicenter prospective study (PLASTIC-study). BMC Cancer. 2018 Apr 20;18(1):450.
  34. Jansen SM, de Bruin DM, van Berge Henegouwen MI, Bloemen PR, Strackee SD, Veelo DP, van Leeuwen TG, Gisbertz SS. Effect of ephedrine on gastric conduit perfusion measured by laser speckle contrast imaging after esophagectomy: a prospective in vivo cohort study. Dis Esophagus. 2018 Apr 13.
  35. Gooszen JAH, Slaman AE, van Dieren S, Gisbertz SS, van Berge Henegouwen MI. Incidence and Treatment of Symptomatic Diaphragmatic Hernia After Esophagectomy for Cancer. Ann Thorac Surg. 2018 Jul;106(1):199-206.
  36. Gooszen JAH, Goense L, Gisbertz SS, Ruurda JP, van Hillegersberg R, van Berge Henegouwen MI. Intrathoracic versus cervical anastomosis and predictors of anastomotic leakage after oesophagectomy for cancer. Br J Surg. 2018 Apr;105(5):552-560.
  37. Beck N, Busweiler LAD, Schouwenburg MG, Fiocco M, Cats A, Voncken FEM, Wijnhoven BPL, van Berge Henegouwen MI, Wouters MWJM, van Sandick JW; Dutch Upper GI Cancer Audit (DUCA) Group and the Dutch Gastric Cancer Perioperative Therapy Study group. Factors contributing to variation in the use of multimodality treatment in patients with gastric cancer: A Dutch population based study. Eur J Surg Oncol. 2018 Feb;44(2):260-267.
  38. Jansen SM, de Bruin DM, van Berge Henegouwen MI, Strackee SD, Veelo DP, van Leeuwen TG, Gisbertz SS. Can we predict necrosis intra-operatively? Real-time optical quantitative perfusion imaging in surgery: study protocol for a prospective, observational, in vivo pilot study. Pilot Feasibility Stud. 2017 Nov 25;3:65.
  39. Low DE, Kuppusamy MK, Alderson D, Cecconello I, Chang AC, Darling G, Davies A, D'Journo XB, Gisbertz SS, Griffin SM, Hardwick R, Hoelscher A, Hofstetter W, Jobe B, Kitagawa Y, Law S, Mariette C, Maynard N, Morse CR, Nafteux P, Pera M, Pramesh CS, Puig S, Reynolds JV, Schroeder W, Smithers M, Wijnhoven BPL. Benchmarking Complications Associated with Esophagectomy. Ann Surg. 2017 Dec 4.
  40. Visser E, van Rossum PSN, van Veer H, Al-Naimi K, Chaudry MA, Cuesta MA, Gisbertz SS, Gutschow CA, Hölscher AH, Luyer MDP, Mariette C, Moorthy K, Nieuwenhuijzen GAP, Nilsson M, Räsänen JV, Schneider PM, Schröder W, Cheong E, van Hillegersberg R. A structured training program for minimally invasive esophagectomy for esophageal cancer- a Delphi consensus study in Europe. Dis Esophagus. 2018 Mar 1;31(3).
  41. Pilot-study on the feasibility of sentinel node navigation surgery in combination with thoracolaparoscopic lymphadenectomy without esophagectomy in early esophageal adenocarcinoma patients. Künzli HT, van Berge Henegouwen MI, Gisbertz SS, van Esser S, Meijer SL, Bennink RJ, Wiezer MJ, Seldenrijk CA, Bergman JJGHM, Weusten BLAM. Dis Esophagus. 2017 Nov 1;30(11):1-8.
  42. Treatment strategies in recurrent esophageal or junctional cancer. Butter R, Lagarde SM, van Oijen MGH, Anderegg MCJ, Gisbertz SS, Meijer SL, Hulshof MCCM, Bergman JJGHM, van Berge Henegouwen MI, van Laarhoven HWM. Dis Esophagus. 2017 Sep 1;30(9):1-9.
  43. Learning Curve and Associated Morbidity of Minimally Invasive Esophagectomy: A Retrospective Multicenter Study. van Workum F, Stenstra MHBC, Berkelmans GHK, Slaman AE, van Berge Henegouwen MI, Gisbertz SS, van den Wildenberg FJH, Polat F, Irino T, Nilsson M, Nieuwenhuijzen GAP, Luyer MD, Adang EM, Hannink G, Rovers MM, Rosman C. Ann Surg. 2017 Aug 29.
  44. Predictive factors for post-operative respiratory infections after esophagectomy for esophageal cancer: outcome of randomized trial. Biere SS, van Berge Henegouwen MI, Bonavina L, Rosman C, Roig Garcia J, Gisbertz SS, van der Peet DL, Cuesta MA. J Thorac Dis. 2017 Jul;9(Suppl 8):S861-S867.
  45. Gastro-esophageal junction cancers: what is the best minimally invasive approach? Jezerskyte E, van Berge Henegouwen MI, Cuesta MA, Gisbertz SS. J Thorac Dis. 2017 Jul;9(Suppl 8):S751-S760.
  46. The extent of lymphadenectomy in esophageal resection for cancer should be standardized. Hagens ERC, van Berge Henegouwen MI, Cuesta MA, Gisbertz SS. J Thorac Dis. 2017 Jul;9(Suppl 8):S713-S723.
  47. Defining Benchmarks for Transthoracic Esophagectomy: A Multicenter Analysis of Total Minimally Invasive Esophagectomy in Low Risk Patients. Schmidt HM, Gisbertz SS, Moons J, Rouvelas I, Kauppi J, Brown A, Asti E, Luyer M, Lagarde SM, Berlth F, Philippron A, Bruns C, Hölscher A, Schneider PM, Raptis DA, Henegouwen MIVB, Nafteux P, Nilsson M, Räsanen J, Palazzo F, Rosato E, Mercer S, Bonavina L, Nieuwenhuijzen G, Wijnhoven BPL, Schröder W, Pattyn P, Grimminger PP, Gutschow CA. Ann Surg. 2017 Aug 7.
  48. A Propensity Score Matched Analysis of Open Versus Minimally Invasive Transthoracic Esophagectomy in the Netherlands. Seesing MFJ, Gisbertz SS, Goense L, van Hillegersberg R, Kroon HM, Lagarde SM, Ruurda JP, Slaman AE, van Berge Henegouwen MI, Wijnhoven BPL. Ann Surg. 2017 Aug 8
  49. Postoperative Outcomes of Minimally Invasive Gastrectomy Versus Open Gastrectomy During the Early Introduction of Minimally Invasive Gastrectomy in the Netherlands: A Population-based Cohort Study. Brenkman HJF, Gisbertz SS, Slaman AE, Goense L, Ruurda JP, van Berge Henegouwen MI, van Hillegersberg R; Dutch Upper Gastrointestinal Cancer Audit (DUCA) group. Ann Surg. 2017 Jul 24.
  50. Preoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma. Anderegg MCJ, van der Sluis PC, Ruurda JP, Gisbertz SS, Hulshof MCCM, van Vulpen M, Mohammed NH, van Laarhoven HWM, Wiezer MJ, Los M, van Berge Henegouwen MI, van Hillegersberg R. Ann Surg Oncol. 2017 Aug;24(8):2282-2290.
  51. Impact of Surgical Approach on Long-term Survival in Esophageal Adenocarcinoma Patients With or Without Neoadjuvant Chemoradiotherapy. Noordman BJ, van Klaveren D, van Berge Henegouwen MI, Wijnhoven BP, Gisbertz SS, Lagarde SM, van der Gaast A, Hulshof MC, Biermann K, Steyerberg EW, van Lanschot JJ; also on behalf of the CROSS-study group. Ann Surg. 2017 Mar 27.
  52. Effect of goal-directed therapy on outcome after esophageal surgery: A quality improvement study. Veelo DP, van Berge Henegouwen MI, Ouwehand KS, Geerts BF, Anderegg MC, van Dieren S, Preckel B, Binnekade JM, Gisbertz SS, Hollmann MW. PLoS One. 2017 Mar 2;12(3):e0172806.
  53. Influence of the Extent and Dose of Radiation on Complications After Neoadjuvant Chemoradiation and Subsequent Esophagectomy With Gastric Tube Reconstruction With a Cervical Anastomosis. Koëter M, Kathiravetpillai N, Gooszen JA, van Berge Henegouwen MI, Gisbertz SS, van der Sangen MJ, Luyer MD, Nieuwenhuijzen GA, Hulshof MC. Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):813-821.
  54. Minimally Invasive Versus Open Esophageal Resection: Three-year Follow-up of the Previously Reported Randomized Controlled Trial: the TIME Trial. Straatman J, van der Wielen N, Cuesta MA, Daams F, Roig Garcia J, Bonavina L, Rosman C, van Berge Henegouwen MI, Gisbertz SS, van der Peet DL. Ann Surg. 2017 Aug;266(2):232-236.
  55. Prognostic impact of extracapsular lymph node involvement after neoadjuvant therapy and oesophagectomy. Lagarde SM, Navidi M, Gisbertz SS, van Laarhoven HW, Sumpter K, Meijer SL, Disep B, Immanuel A, Griffin SM, van Berge Henegouwen MI. Br J Surg. 2016 Nov;103(12):1658-1664.
  56. Activities of daily living and quality of life during treatment with neoadjuvant chemoradiotherapy and after surgery in patients with esophageal cancer. Haj Mohammad N, De Rooij S, Hulshof M, Ruurda J, Wijnhoven B, Erdkamp F, Sosef M, Gisbertz S, van Berge Henegouwen M, Sprangers M, van Laarhoven H. J Surg Oncol. 2016 Nov;114(6):684-690.
  57. Intrathoracic versus Cervical ANastomosis after minimally invasive esophagectomy for esophageal cancer: study protocol of the ICAN randomized controlled trial. van Workum F, Bouwense SA, Luyer MD, Nieuwenhuijzen GA, van der Peet DL, Daams F, Kouwenhoven EA, van Det MJ, van den Wildenberg FJ, Polat F, Gisbertz SS, Henegouwen MI, Heisterkamp J, Langenhoff BS, Martijnse IS, Grutters JP, Klarenbeek BR, Rovers MM, Rosman C. Trials. 2016 Oct 18;17(1):505.
  58. Prognostic Significance of the Location of Lymph Node Metastases in Patients With Adenocarcinoma of the Distal Esophagus or Gastroesophageal Junction. Anderegg MC, Lagarde SM, Jagadesham VP, Gisbertz SS, Immanuel A, Meijer SL, Hulshof MC, Bergman JJ, van Laarhoven HW, Griffin SM, van Berge Henegouwen MI. Ann Surg. 2016 Nov;264(5):847-853.
  59. Development and feasibility of a web-based question prompt sheet to support information provision of health-related quality of life topics after oesophageal cancer surgery. Jacobs M, Henselmans I, Arts DL, Ten Koppel M, Gisbertz SS, Lagarde SM, van Berge Henegouwen MI, Sprangers MA, de Haes HC, Smets EM. Eur J Cancer Care (Engl). 2016 Oct 13.
  60. Surgical anatomy of the supracarinal esophagus based on a minimally invasive approach: vascular and nervous anatomy and technical steps to resection and lymphadenectomy. Cuesta MA, van der Wielen N, Weijs TJ, Bleys RL, Gisbertz SS, van Duijvendijk P, van Hillegersberg R, Ruurda JP, van Berge Henegouwen MI, Straatman J, Osugi H, van der Peet DL. Surg Endosc. 2017 Apr;31(4):1863-1870.
  61. Role of omentectomy as part of radical surgery for gastric cancer. EJ Jongerius, D Boerma, CA Seldenrijk, SL Meijer, JJG Scheepers, F Smedts, SM Lagarde, O Balague Ponz, MI van Berge Henegouwen, JW van Sandick, SS Gisbertz. Br J Surg. 2016 Oct;103(11):1497-503.
  62. Laser speckle contrast imaging identifies ischemic areas on gastric tube reconstructions following esophagectomy. Milstein DM, Ince C, Gisbertz SS, Boateng KB, Geerts BF, Hollmann MW, van Berge Henegouwen MI, Veelo DP. Medicine (Baltimore). 2016 Jun;95(25):e3875.
  63. Using the Comprehensive Complication Index to Assess the Impact of Neoadjuvant Chemoradiotherapy on Complication Severity After Esophagectomy for Cancer. Nederlof N, Slaman AE, van Hagen P, van der Gaast A, Slankamenac K, Gisbertz SS, van Lanschot JJ, Wijnhoven BP, van Berge Henegouwen MI; CROSS-Study Group. Ann Surg Oncol. 2016 Nov;23(12):3964-3971.
  64. Techniques and short-term outcomes for total minimally invasive Ivor Lewis esophageal resection in distal esophageal and gastroesophageal junction cancers: pooled data from six European centers. Straatman J, van der Wielen N, Nieuwenhuijzen GA, Rosman C, Roig J, Scheepers JJ, Cuesta MA, Luyer MD, van Berge Henegouwen MI, van Workum F, Gisbertz SS, van der Peet DL. Surg Endosc. 2017 Jan;31(1):119-126.
  65. 18F-FDG PET-CT after neoadjuvant chemoradiotherapy in oesophageal cancer patients to optimize surgical decision making. MCJ Anderegg, EJ de Groof, SS Gisbertz, RJ Bennink, SM Lagarde, JHG Klinkenbijl, SSKS Phoa, MGW Dijkgraaf, JJGHM Bergman, MCCM Hulshof, HWM van Laarhoven, MI van Berge Henegouwen. PLoS One. 2015 Nov 3;10(11):e0133690.
  66. Metformin Use During Treatment of Potentially Curable Esophageal Cancer Patients is not Associated with Better Outcomes. Spierings LE, Lagarde SM, van Oijen MG, Gisbertz SS, Wilmink JW, Hulshof MC, Meijer SL, Anderegg MC, van Berge Henegouwen MI, van Laarhoven HW. Ann Surg Oncol. 2015 Dec;22 Suppl 3:766-71.
  67. A Quantified Scoring System for Postoperative Complication Severity Compared to the Clavien-Dindo Classification. Slaman AE, Lagarde SM, Gisbertz SS, van Berge Henegouwen MI. Dig Surg. 2015;32(5):361-6.
  68. The effect of on-demand vs deep neuromuscular relaxation on rating of surgical and anaesthesiologic conditions in patients undergoing thoracolaparoscopic esophagectomy (DEPTH trial): study protocol for a randomized controlled trial. Veelo DP, Gisbertz SS, Hannivoort RA, van Dieren S, Geerts BF, van Berge Henegouwen MI, Hollmann MW. Trials. 2015 Aug 5;16(1):331.
  69. Thoracolaparoscopic dissection of esophageal lymph nodes without esophagectomy is feasible in human cadavers and safe in a porcine survival study. Künzli HT, van Berge Henegouwen M, Gisbertz S, Seldenrijk C, Kuijpers K, Bergman J, Wiezer M, Weusten B. Dis Esophagus. 2015 Jul 30. doi: 10.1111/dote.12395.
  70. Laparoscopic versus open gastrectomy for gastric cancer, a multicenter prospectively randomized controlled trial (LOGICA-trial). Haverkamp L, Brenkman HJ, Seesing MF, Gisbertz SS, van Berge Henegouwen MI, Luyer MD, Nieuwenhuijzen GA, Wijnhoven BP, van Lanschot JJ, de Steur WO, Hartgrink HH, Stoot JH, Hulsewé KW, Spillenaar Bilgen EJ, Rütter JE, Kouwenhoven EA, van Det MJ, van der Peet DL, Daams F, Draaisma WA, Broeders IA, van Stel HF, Lacle MM, Ruurda JP, van Hillegersberg R; LOGICA study group. BMC Cancer. 2015 Jul 29;15(1):556.
  71. Quality of Life and Late Complications After Minimally Invasive Compared to Open Esophagectomy: Results of a Randomized Trial. Maas KW, Cuesta MA, van Berge Henegouwen MI, Roig J, Bonavina L, Rosman C, Gisbertz SS, Biere SS, van der Peet DL. World J Surg. 2015 Jun 3.
  72. Surgical techniques, open versus minimally invasive gastrectomy after chemotherapy (STOMACH trial): study protocol for a randomized controlled trial. Straatman J, van der Wielen N, Cuesta MA, Gisbertz SS, Hartemink KJ, Alonso Poza A, Weitz J, Mateo Vallejo F, Ahktar K, Diez Del Val I, Roig Garcia J, van der Peet DL. Trials. 2015 Mar 27;16:123.
  73. Reduction of heart volume during neoadjuvant chemoradiation in patients with resectable esophageal cancer. Haj Mohammad N, Kamphuis M, Hulshof MC, Lutkenhaus LJ, Gisbertz SS, Bergman JJ, de Bruin-Bon HA, Geijsen ED, Bel A, Boekholdt SM, van Laarhoven HW. Radiother Oncol. 2015 Jan;114(1):91-5. doi: 10.1016/j.radonc.2014.12.005. Epub 2015 Jan 24.
  74. Value of a step-up diagnosis plan: CRP and CT-scan to diagnose and manage postoperative complications after major abdominal surgery. Straatman J, Cuesta MA, Gisbertz SS, Van der Peet DL. Rev Esp Enferm Dig. 2014 Dec;106(8):515-521.
  75. A new concept of the anatomy of the thoracic oesophagus: the meso-oesophagus. Observational study during thoracoscopic esophagectomy. Cuesta MA, Weijs TJ, Bleys RL, van Hillegersberg R, van Berge Henegouwen MI, Gisbertz SS, Ruurda JP, Straatman J, Osugi H, van der Peet DL. Surg Endosc. 2014 Dec 6.
  76. Laparoscopic surgery for gastro-esophageal acid reflux disease. Schijven MP, Gisbertz SS, van Berge Henegouwen MI. Best Pract Res Clin Gastroenterol. 2014 Feb;28(1):97-109.
  77. Minimally invasive surgery for oesophageal cancer. Anderegg MC, Gisbertz SS, van Berge Henegouwen MI. Best Pract Res Clin Gastroenterol. 2014 Feb;28(1):41-52.
  78. Minimally invasive esophageal resection for cancer: a randomized controlled trial. Biere SSAY, van Berge Henegouwen MI, Maas KW, Bonavina L, Rosman C, Roig Garcia J, Gisbertz SS, Klinkenbijl JH, Hollmann MW, de Lange ESM, Bonjer HJ, van der Peet DL, Cuesta MA. Lancet. 2012 May 19;379(9829):1887-92.
  79. Laparoscopic versus open transhiatal esophagectomy. Maas KW, Biere SSAY, Scheepers JJG, Gisbertz SS, van der Peet DL, Cuesta MA. Rev Esp Enferm Dig 2012 Apr; 104(4):197-202.
  80. Minimally invasive intrathoracic anastomosis after Ivor Lewis esophagectomy for cancer: a review of transoral or transthoracic use of staplers. Maas KW, Biere SS, Scheepers JJ, Gisbertz SS, Turrado Rodriguez V, van der Peet DL, Cuesta MA. Surg Endosc. 2012 Jul;26(7):1795-802.
  81. The effect of alcohol on atherosclerotic plaque composition and cardiovascular events in patients with arterial occlusive disease. Gisbertz SS, Derksen WJ, de Kleijn DP, Vink A, van der Graaf Y, de Vries JP, Moll FL, Pasterkamp G. J Vasc Surg 2011 Jul;54(1):123-31.
  82. Remote endarterectomy versus supragenicular bypass surgery for long occlusions of the superficial femoral artery: medium-term results of a randomized controlled trial. [The REVAS trial]. Gisbertz SS, de Borst GJ, Hoedt MT, Ho G, Overtoom TTh, Moll FL, de Vries JP. Ann Vasc Surg. 2010 Nov;24(8):1015-23.
  83. Predictive risk factors for restenosis after remote superficial femoral artery endarterectomy. Derksen WJM, Gisbertz SS, Hellings WE, Vink A, de Kleijn DP, Moll FL, de Vries JP, Pasterkamp G. Eur J Vasc Surg. 2010;39(5):597-603.
  84. Blinded randomized clinical trial of botulinum toxin versus isosorbide dinitrate ointment for treatment of anal fissure. Festen S, Gisbertz SS, van Schaagen F, Gerhards MF. Br J Surg. 2009;96(12):1393-9.
  85. Initial results of concomitant cryoplasty after remote endarterectomy of the superficial femoral artery; A feasibility study. Gisbertz SS, de Borst GJ, Overtoom TTh, Moll FL, de Vries JPPM. Vasc Endovasc Surg. 2010;44(1):20-4.
  86. Short-term results of a randomized trial comparing remote endarterectomy and supragenicular bypass surgery for long occlusions of the superficial femoral artery. [The REVAS trial]. Gisbertz SS, Ramzan M, Tutein Nolthenius RP, van der Laan L, Moll FL, de Vries JP. Eur J Vasc Endovasc Surg. 2009;37(1):68-76.
  87. Remote superficial femoral artery endarterectomy. Derksen WJ, Gisbertz SS, Pasterkamp G, de Vries JP, Moll FL. J Cardiovasc Surg (Torino). 2008;49(2):193-8.
  88. Variable mannose-binding lectin expression during postoperative acute-phase response. Van Till JWO, Boermeester MA, Modderman PW, van Sandick  JW, Hart MH, Gisbertz SS, van Lanschot JJB, Aarden LA. Surg Infect (Larchmt). 2006; 7(5): 443-52..
  89. Remote superficial femoral artery endarterectomy and distal aSpire stenting: results of a multinational study at three-year follow-up. Rosenthal D, Martin JD, Smeets L, de Vries JP, Gisbertz SS, Wellons ED, Moll FL. J Cardiovasc Surg (Torino). 2006; 47(4): 385-91.
  90. Does conversion of intended remote iliac artery endarterectomy alter the early and long-term outcome? Smeets L, van der Horn G, Gisbertz SS, Ho G, Moll FL. Vascular. 2005;13(6): 336-42.
  91. Future perspectives in the treatment of femoro-popliteal arterial occlusions. Gisbertz SS, Hissink RJ, de Vries JP, Moll FL. J Cardiovasc Surg (Torino). 2005; 46(4): 371-84.
  92. Treatment of fistulas in ano with fibrin glue. Gisbertz SS, Sosef MN, Festen S, Gerhards MF. Dig Surg. 2005; 22(1-2): 91-4.
  93. Lymphocyte subsets and Th1/Th2 immune responses in patients with adenocarcinoma of the esophagus or the esophagogastric junction: relation to pTNM stage and clinical outcome. Van Sandick JW, Boermeester MA, Gisbertz SS, ten Berge IJM, Out TA, van der Pouw Kraan TCTM, van Lanschot JJB. Cancer Immunol Immunother. 2003;52(10):617-24.
  94. Immune responses and prediction of major infection in patients undergoing transhiatal or transthoracic esophagectomy for cancer. Van Sandick JW, Gisbertz SS, ten Berge IJM, Boermeester MA, van der Pouw Kraan TCTM, Out TA, Obertop H, van Lanschot JJB. Ann Surg.2003; 237(1): 35-43.

 

 

Other Publications

  1. Minimally Invasive Esophagectomy. Zhigang Li, Toni Lerut, Suzanne S. Gisbertz sds. 2018. ISBN978-988-79496-4-0.
  2. Minimally Invasive Approach of Gastro-esophageal Junction cancer. AS Slaman, van Berge Henegouwen, SS Gisbertz.  In MA Cuesta eds. Minimally Invasive Surgery for Upper Abdominal Cancer. ISBN: 978-3-319-54300-0 (print, hardcover), ISBN: 978-3-319-54301-7 (e-book).
  3. Oesophaguscarcinoom. L Noteboom, SS Gisbertz. Nurse Academy, nummer 1, 2017.  
  4. General Principles of Recognition of Major Complications Following Surgery of the Digestive Tract. Gisbertz SS, Straatman J, Cuesta MA. In Cuesta MA, Bonjer HJ, eds. Treatment of Postoperative Complications After Digestive Surgery. ISBN: 978-1-4471-4353-6 (Print) 978-1-4471-4354-3 (Online).
  5. Case on Biliary Leakage and Abscess After Liver Resection. Gisbertz SS. In Cuesta MA, Bonjer HJ, eds. Case Studies of Postoperative Complications after Digestive Surgery. ISBN: 978-3-319-01612-2 (Print) 978-3-319-01613-9 (Online).
  6. Case on Postoperative Bleeding After Whipple Procedure. Gisbertz SS, Cuesta MA. In Cuesta MA, Bonjer HJ, eds. Case Studies of Postoperative Complications after Digestive Surgery. ISBN: 978-3-319-01612-2 (Print) 978-3-319-01613-9 (Online).
  7. Case on Leakage of the Pancreato-Jejunostomy After a Whipple Procedure. Gisbertz SS. In Cuesta MA, Bonjer HJ, eds. Case Studies of Postoperative Complications after Digestive Surgery. ISBN: 978-3-319-01612-2 (Print) 978-3-319-01613-9 (Online).
  8. Case on Bleeding in the Small Remnant of the Head of the Pancreas After Duodenum Preserving Resection for Middle Pancreatic Tumor. Gisbertz SS, Lely RJ. In Cuesta MA, Bonjer HJ, eds. Case Studies of Postoperative Complications after Digestive Surgery. ISBN: 978-3-319-01612-2 (Print) 978-3-319-01613-9 (Online).
  9. Case on Pseudocyst of the Pancreas, Endoscopically or Surgical Treatment? Gisbertz SS, Jacobs MA. In Cuesta MA, Bonjer HJ, eds. Case Studies of Postoperative Complications after Digestive Surgery. ISBN: 978-3-319-01612-2 (Print) 978-3-319-01613-9 (Online).
  10. Case on Postoperative Abscess After Appendicectomy. Gisbertz SS. In Cuesta MA, Bonjer HJ, eds. Case Studies of Postoperative Complications after Digestive Surgery. ISBN: 978-3-319-01612-2 (Print) 978-3-319-01613-9 (Online).
  11. Case on Recurrence After TME Because of Rectal Cancer. Gisbertz SS, Cuesta MA. In Cuesta MA, Bonjer HJ, eds. Case Studies of Postoperative Complications after Digestive Surgery. ISBN: 978-3-319-01612-2 (Print) 978-3-319-01613-9 (Online).
  12. Case on Complications and Approach in Post-radiation Enteritis. Gisbertz SS. In Cuesta MA, Bonjer HJ, eds. Case Studies of Postoperative Complications after Digestive Surgery. ISBN: 978-3-319-01612-2 (Print) 978-3-319-01613-9 (Online).
  13. Case on Rectovaginal Fistula Following Delivery. Gisbertz SS. In Cuesta MA, Bonjer HJ, eds. Case Studies of Postoperative Complications after Digestive Surgery. ISBN: 978-3-319-01612-2 (Print) 978-3-319-01613-9 (Online).
  14. Thoracscopic esophagectomy. Cuesta MA, van der Peet DL, Biere SSAY, Gisbertz SS, van Berge Henegouwen MI,. In Bonavina ed. Innovation in esophageal surgery.1st ed. London, Pa: Springer; 2012.
  15. Endarterectomy for Infrainguinal Arterial Occlusive Disease. Gisbertz SS, de Vries JP, Moll FL. In Moore WS, Ahn SS, eds. Endovascular Surgery. 5th ed. Philadelphia, Pa: W.B. Saunders; 2010.
  16. Distal Cutting Endarterectomy. Gisbertz SS, Vries JP, Moll FL. In Greenhalgh RM, ed. 2008: 29th Symposium Book Charing xCross. Vascular and Endovascular Consensus Update, April 2008.
  17. Evisceratie. Gisbertz SS. In Bemelman M, Leenen LP, de Vries GM, Holtslag HR, eds. Multidisciplinaire traumazorg in de regio Utrecht. Bloemlezing ketenavonden 2007.
  18. Superficial Femoral Artery Hemodynamics. Gisbertz SS, Moll FL. In Cairols MA, ed. IX Vascular Monographies: Carpe Diem Consensus and Trials. Syllabus de las Monografías, November 2007.

 

 

Abstracts & lectures (incomplete)

  1. Invited speaker at UEGW 2019
  2. Invited speaker at OESO 2019
  3. Invited speaker at NVGIC congress 2019
  4. Invited speaker at EGCC 2019
  5. Invited speaker ISDE 2018
  6. 8 posters/2 lectures at ISDE 2018
  7. Invited lecture at EAES 2018
  8. Invited lectures (3 Rio de Janeiro)
  9. Invited lecture SAGES 2018
  10. 2 invited lectures, OESO, September 2017, Geneve, France.
  11. Transthoracic versus transhiatal esophagectomy for esophageal cancer: a nation-wide propensity score matched cohort analysis. A.C. Mertens, M.C. Kalff, W.J. Eshuis, Prof. T.M. van Gulik, Prof. M.I. van Berge Henegouwen,
  12. S.S. Gisbertz, on behalf of the Dutch Upper GI Cancer Audit group. Chirurgendagen 2019.
  13. Transthoracic versus transhiatal esophagectomy for esophageal cancer: a nation-wide propensity score matched cohort analysis. A.C. Mertens, M.C. Kalff, W.J. Eshuis, Prof. T.M. van Gulik, Prof. M.I. van Berge Henegouwen,
  14. S.S. Gisbertz, on behalf of the Dutch Upper GI Cancer Audit group. ESA 2019.
  15. Transthoracic versus transhiatal esophagectomy for esophageal cancer: a nation-wide propensity score matched cohort analysis. A.C. Mertens, M.C. Kalff, W.J. Eshuis, Prof. T.M. van Gulik, Prof. M.I. van Berge Henegouwen,
  16. S.S. Gisbertz, on behalf of the Dutch Upper GI Cancer Audit group. DICA congress 2019.
  17. Transthoracic versus transhiatal esophagectomy for esophageal cancer: a nation-wide propensity score matched cohort analysis. A.C. Mertens, M.C. Kalff, W.J. Eshuis, Prof. T.M. van Gulik, Prof. M.I. van Berge Henegouwen,
  18. S.S. Gisbertz, on behalf of the Dutch Upper GI Cancer Audit group. Digestive Disease Days 2019.
  19. Transthoracic versus transhiatal esophagectomy for esophageal cancer: a nation-wide propensity score matched cohort analysis. A.C. Mertens, M.C. Kalff, W.J. Eshuis, Prof. T.M. van Gulik, Prof. M.I. van Berge Henegouwen,
  20. S.S. Gisbertz, on behalf of the Dutch Upper GI Cancer Audit group. ISDE 2019.
  21. The association of perioperative quality-of-care parameters  (textbook outcome) with long term outcome after esophagectomy for esophageal cancer (144/150 characters). M.C. Kalff, I. Vesseur, W. Eshuis, D. Heineman, F. Daams, D.L. van der Peet, S.S. Gisbertz, M.I. van Berge Henegouwen. Digestive Disease Days, ISDE 2019.
  22. The association of perioperative quality-of-care parameters  (textbook outcome) with long term outcome after esophagectomy for esophageal cancer (144/150 characters). M.C. Kalff, I. Vesseur, W. Eshuis, D. Heineman, F. Daams, D.L. van der Peet, S.S. Gisbertz, M.I. van Berge Henegouwen. Digestive Disease Days 2019.
  23. C-reactive protein as a marker for anastomotic leakage after esophageal surgery. Eliza R.C. Hagens, MD; Wing C. Lam, MSc; W.J. Eshuis, MD PhD; W. Lameris, MD PhD; Mark I. van Berge Henegouwen, MD PhD; Suzanne S. Gisbertz, MD PhD. Digestive Disease Days 2019, ESDE 2019 and UEGW 2019.
  24. Conditional survival in patients with resectable esophageal cancer. E.R.C. Hagens MD, M.L. Feenstra MD, M.I. van Berge Henegouwen MD, PhD, W.J. Eshuis MD, PhD, M.C.C.M. Hulshof, MD, PhD, H.W.M. van Laarhoven MD, PhD, PhD, S.S. Gisbertz MD, PhD. Digestive Disease Days 2019, ESDE 2019 and UEGW 2019.
  25. The impact of paratracheal lymphadenectomy on lymph node yield and short-term outcomes in esophagectomy: a national propensity score matched analysis. BF Kingma, ERC Hagens, MI van Berge Henegouwen, AS Borggreve, JP Ruurda, SS Gisbertz, R van Hillegersberg. ESDE 2019.
  26. Predictors for anastomotic leakage after esophagectomy and impact on survival. Eliza R.C. Hagens, MD; Maud A. Reijntjes, BSc, MD PhD; M.C.J. Anderegg, MD PhD; W.J. Eshuis, MD PhD; Suzanne S. Gisbertz, MD PhD; Mark I. van Berge Henegouwen, MD PhD; ESDE 2019
  27. Long term quality of life in patients after McKeown versus Ivor Lewis esophagectomy Egle Jezerskyte BSc, L.M. Saadeh MD, E.R.C. Hagens, M.A.G. Sprangers MD, PhD, L. Noteboom, MSc, H.W.M. van Laarhoven MD, PhD, W.J. Eshuis MD, M.I. van Berge Henegouwen MD, PhD, S.S. Gisbertz MD, PhD. ISDE 2018 and Digestive Disease Days 2018.
  28. Long term quality of life in patients after total gastrectomy versus Ivor Lewis esophagectomy. Egle Jezerskyte BSc, L.M. Saadeh MD, E.R.C. Hagens, M.A.G. Sprangers MD, PhD, L. Noteboom, MSc, H.W.M. van Laarhoven MD, PhD, W.J. Eshuis MD, M.I. van Berge Henegouwen MD, PhD, S.S. Gisbertz MD, PhD. ESDE 2017, 2nd International Gastric Cancer Congress 2017 and IGCC, Prague 2019.
  29. International Survey on the Management of Anastomotic Leakage After Esophageal Resection. Hagens ERC, Anderegg MCJ, van Berge Henegouwen MI, Gisbertz SS. Ann Thorac Surg. June 2018. doi:10.1016/j.athoracsur.2018.05.009. OESO 2017.
  30. Distribution of lymph node metastases in esophageal carcinoma [TIGER]: Study protocol. Eliza RC Hagens, BSc; Mark I van Berge Henegouwen, TIGER study group, Suzanne S Gisbertz, MD, PhD. AG&M 2018
  31. Impact of body composition and muscle strength on outcomes following surgery for esophageal cancer. Hagens, ERC, BSc, Feenstra, ML, BSc, P. Boshier, Egmond van M, titel, Haverkort, EB, PhD, van Berge Henegouwen MI, MD, PhD, Gisbertz, SS,MD, PhD. ISDE 2018
  32. Impact of body composition and muscle strength on outcomes following surgery for esophageal cancer. Hagens, ERC, BSc, Feenstra, ML, BSc, P. Boshier, Egmond van M, titel, Haverkort, EB, PhD, van Berge Henegouwen MI, MD, PhD, Gisbertz, SS,MD, PhD. ESDE 2017
  33. Distribution of lymph node metastases in esophageal carcinoma [TIGER]: Study protocol. Eliza RC Hagens, BSc; Mark I van Berge Henegouwen, TIGER study group, Suzanne S Gisbertz, MD, PhD. iSDE 2018
  34. International Survey on the Management of Anastomotic Leakage After Esophageal Resection. Hagens ERC, Anderegg MCJ, van Berge Henegouwen MI, Gisbertz SS. Ann Thorac Surg. June 2018. doi:10.1016/j.athoracsur.2018.05.009. ESDE 2017 en ISDE 2018
  35. International Survey on the Management of Anastomotic Leakage After Esophageal Resection. Hagens ERC, Anderegg MCJ, van Berge Henegouwen MI, Gisbertz SS. Ann Thorac Surg. June 2018. doi:10.1016/j.athoracsur.2018.05.009. ESDE 2017 en ISDE 2018
  36. Kroon HM, Seesing MF, Gisbertz SS, Goense L, van Hillegersberg R, Lagarde S, Ruurda JP, Slaman AE, van Berge Henegouwen MI, Wijnhoven BPL..A propensity score matched analysis of open versus minimally invasive transthoracic esophagectomy in the Netherlands. Annual Australian College of Surgeons Meeting, May 2017, Adelaide, Australia (ANZ J Surg 2017;87(S1):140).
  37. Neutrophil lymphocyte ratio as predictive marker of survival in esophageal cancer: systematic review and meta-analysis. UEGW Barcelona 2017.
  38. pre-treatment NLR. UEGW Barcelona 2017.
  39. Een propensity score matched analyse van open versus minimaal invasieve transthoracale oesophagusresectie in Nederland. Seesing, van Berge Henegouwen, Gisbertz. Chirurgendagen Mei 2017.
  40. Quality of life after esophagectomy versus gastrectomy. E. Jezerskyte, MI van Berge Henegouwen, SS Gisbertz. IGGC, April 2017, Beijing, China.
  41. Complications after gastrectomy for cancer. Gian Luca Baiocchi. IGGC, April 2017, Beijing, China.
  42. Complications after gastrectomy and countermeasures. Gian Luca Baiocchi. IGGC, April 2017, Beijing, China.
  43. LOGICA trial: how to introduce minimally invasive gastrectomy in the western countries with low incidence of gastric cancer. R. van Hillegersberg. IGGC, April 2017, Beijing, China.
  44. 2 presentations LOGICA study. IGGC, April 2017, Beijing, China.
  45. A propensity score matched analysis of open versus minimally invasive transthoracic esophagectomy in the Netherlands. Seesing van Berge Henegouwen Gisbertz NVGE, Maart 2017, Veldhoven, Nederland.
  46. Quality of life after esophagectomy versus gastrectomy. E. Jezerskyte, MI van Berge Henegouwen, SS Gisbertz, NVGE Maart 2017, Veldhoven, Nederland.
  47. Evaluation of a novel molecular host response assay to diagnose infection in patients after high-risk gastro-intestinal surgery: a pilot study. D.M. Verboom, M.E. Koster-Brouwer, K. van de Groep, J.F. Frencken, B. Scicluna, S.S. Gisbertz, M.I. van Berge Henegouwen, J.P. Ruurda, R. van Hillegersberg, T. van der Poll, M.J.M. Bonten, O.L. Cremer Internationale Sepsis Forum 2016.
  48. Underweight is associated with a higher morbidity and mortality after esophageal surgery; a dutch nation-wide analysis. Gooszen, Blom, Gisbertz, van Berge Henegouwen. ESDE, December 2016, München, Germany.
  49. Anastomotic leakage after esophagectomy: Cervical versus Intrathoracic anastomosis and predictors for its development. J.A.H. Gooszen, L. Goense, S.S. Gisbertz, J.P. Ruurda, R. van Hillegersberg, M.I. van Berge Henegouwen. ESDE, December 2016, München, Germany.
  50. Dynamics of the HER2 receptor in Esophageal Adenocarcinoma; new opportunities for targeted therapy. A. Creemers, E. A. Ebbing, G.K.J. Hooijer, R.A. Jibodh-Mulder, S. S. Gisbertz, M.I. van Berge Henegouwen, M.G.H. van Oijen, M.F. Bijlsma, S.L. Meijer, H.W.M. van Laarhoven. ESMO, October 2016, Copenhagen, Denmark.
  51. Measuring Perfusion with Light. Jansen SM, de Bruin DM, van Berge Henegouwen MI, Veelo DP, van Leeuwen TG, Strackee SD, Gisbertz SS. Skin Laser Imaging – BMBS COST ACTION, Split, Croatia, September 2015.
  52. The effect of intra-operative goal directed fluid therapy (GDFT) on outcome after esophageal surgery- a Quality Improvement Study. Denise P. Veelo, MD, PhD, Mark I. van Berge Henegouwen MD, PhD, Kirsten S. Ouwehand, MD, Bart F. Geerts, MD, PhD, Maarten C.J. Anderegg MD, Susan van Dieren, MD, PhD, Jan M. Binnekade, Msc, PhD, Suzanne S. Gisbertz, MD, PhD, Markus W. Hollmann, MD, PhD. ISDE. Singapore, Singapore, September 2016.
  53. The influence of radiation dose on complications after neoadjuvant chemoradiation and a subsequent esophagectomy with cervical anastomosis. M. Koëter, MD, N. Kathiravetpillai, MD, J.A. Gooszen, MD, M.I. van Berge Henegouwen, MD, PhD, S.S. Gisbertz, MD, PhD, M.J.C. van der Sangen, MD, PhD, M.D.P. Luyer, MD, PhD, G.A.P. Nieuwenhuijzen, MD, PhD, M.C.C.M. Hulshof, MD, PhD. ISDE. Singapore, Singapore, September 2016.
  54. Differences in oncologic esophageal surgery in terms of surgical approach and extent of lymphadenectomy: findings of an international survey on the surgical treatment of oesophageal cancer. A van Rijswijk, MI van Berge Henegouwen, DL van der Peet, SS Gisbertz. ISDE. Singapore, Singapore, September 2016.
  55. Improved anastomotic leakage rates in patients following Ivor Lewis esophagectomy with omental wrap and pleural flap. AE Slaman, JAH Gooszen, MI van Berge Henegouwen, SS Gisbertz. ISDE. Singapore, Singapore, September 2016.
  56. Long-term survivor after esophagectomy: cross-cultural differences between Dutch and Italian patients in referred quality of life. Annelijn E. Slaman; Luca Saadeh; Suzanne S. Gisbertz; Eleonora Pinto, Silvia Mantoan; Francesco Cavallin; Egle Jezerskyte; Rita Alfieri; Maria Cristina Bellissimo; Matteo Cagol; Carlo Castoro; Marco Scarpa; Mark I. van Berge Henegouwen. ISDE. Singapore, Singapore, September 2016.
  57. Symptomatic diafragmatic hernia after esophageal surgery. JAH Gooszen, AE Slaman, SS Gisbertz, MI van Berge Henegouwen. ISDE. Singapore, Singapore, September 2016.
  58. Prognostic significance of the location of lymph node metastases in patients with adenocarcinoma of the distal esophagus or gastro-esophageal junction. Maarten CJ Anderegg MD, Sjoerd M Lagarde MD,PhD, Vamshi P Jagadesham MD FRCS, Suzanne S Gisbertz MD, PhD, Arul Immanuel MD, Sybren L Meijer MD, PhD, Maarten CCM Hulshof MD, PhD, Jacques JGHM Bergman MD, PhD, Hanneke WM van Laarhoven MD, PhD, S Michael Griffin MD, PhD, Mark I van Berge Henegouwen MD, PhD. ISDE. Singapore, Singapore, September 2016.
  59. Preoperative chemoradiotherapy versus perioperative chemotherapy for patients with resectable esophageal or gastroesophageal junction adenocarcinoma. M.C.J. Anderegg, P.C. van der Sluis, J.P. Ruurda, S.S. Gisbertz, M.C.C.M. Hulshof, M. van Vulpen, N. Haj Mohammed, H.W.M. van Laarhoven, M.I. van Berge Henegouwen, R. van Hillegersberg. Singapore, Singapore, September 2016.
  60. Long-course chemoradiotherapy followed by oesophagectomy for patients with ct4b oesophageal carcinoma: results of a multicenter phase-2 trial. MCJ Anderegg, JP Ruurda, SS Gisbertz, MN Sosef, BPL Wijnhoven, JJB van Lanschot, MCCM Hulshof, JJGHM Bergman, HWM van Laarhoven, MI van Berge Henegouwen. Singapore, Singapore, September 2016.
  61. Distribution of lymph node metastases in esophageal adenocarcinoma after neoadjuvant chemoradiation therapy: a prospective cohort study. H. T. Künzli, A. van Rijswijk, S. L. Meijer, R. D. Mijnals, B.L.A.M. Weusten, E. D. Geijsen, H. W.M. van Laarhoven, M. I. van Berge Henegouwen, S.S. Gisbertz. ISDE. Singapore, Singapore, September 2016.
  62. The severity of complications following esophagectomy after neoadjuvant chemoradiotherapy assessed by the comprehensive complication index. Nederlof N, Slaman AE, van Hagen P, van der Gaast A, Slankamenac K, Gisbertz SS, van Lanschot JJB, Wijnhoven BPL, van Berge Henegouwen MI. On behalf of the surgeons of the CROSS-study group. ISDE. Singapore, Singapore, September 2016.
  63. Intra-operative Real-time Perfusion Diagnostics in Gastric Tube Surgery with Optical Techniques: Optical Coherence Tomography and Fluorescence imaging. Jansen SM, de Bruin DM, van Berge Henegouwen MI, Strackee SD, van Leeuwen TG, Gisbertz SS. ISDE, Singapore, September 2016.
  64. Laser speckle imaging identifies the watershed region during gastric tube reconstruction surgery. Suzanne S. Gisbertz, Dan M.J. Milstein, Can Ince, Kofi B. Boateng, Bart F. Geerts, Markus W. Hollmann, Mark I. van Berge Henegouwen, Denise P. Veelo. ISDE. Singapore, Singapore, September 2016.
  65. Intra-operative Real-time Perfusion Diagnostics in Gastric Tube Surgery with Optical Techniques: Sidestream Darkfield Microscopy and Laser Speckle Contrast Imaging . Jansen SM, de Bruin DM, van Berge Henegouwen MI, Strackee SD, van Leeuwen TG, Gisbertz SS. ISDE, Singapore, September 2016.
  66. Distribution of lymph node metastases in esophageal adenocarcinoma after neoadjuvant chemoradiation therapy: a prospective cohort study. HT Kunzli, AS van Rijswijk, SL Meijer, ED Geijsen, MI van Berge Henegouwen, SS Gisbertz. EAES, Amsterdam, June 2016.
  67. Multicenter feasibility study of chemoradiation, trastuzumab and pertuzumab in resectable HER2+ esophageal carcinoma: the TRAP study. Woude van de, Hulshof, Meijer, Laarhoven van, Berge Henegouwen van, Gisbertz, Los, Krishnadath, Punt, Haj Mohammad, Beerepoot, Creemers, Hospers, Slingerland, Warmerdam, Dieren van, Vijver van de. ASCO, Chicago, USA, May 2016.
  68. Novel Perfusion Diagnostics in Reconstructive Surgery, towards prediction of free flap failure. Jansen SM, de Bruin DM, Strackee SD, Gisbertz SS, van Leeuwen TG. EPRSC-ERC / EURAPS, Brussels, Belgium, May 2016. 
  69. Symptomatische hernia diafragmatica na slokdarmchirurgie. JA Gooszen, SS Gisbertz, AE Slaman, MI van Berge Henegouwen. NVvH, Veldhoven, the Netherlands, May 2016.
  70. Haalbaarheid van verlengde chemoradiotherapie gevolgd door een resectie bij patienten met een cT4b oesophaguscarcinoom. MCJ Anderegg, JP Ruurda, SS Gisbertz, MN Sosef, BPL van Wijnhoven, MCCM Hulshof, JJGHM Bergman, HWM van Laarhoven, MI van Berge Henegouwen. NVvH, Veldhoven, the Netherlands, May 2016.
  71. Overleving na minimaal invasieve versus open slokdarmresectie in patienten met slokdarmkanker. Lange termijn uitkomsten van een gerandomiseerde studie (TIME trial). J Straatman, MA Cuesta, J Roig Garcia, L Bonavina, C Rosman, SS Gisbertz, DL van der Peet. NVvH, Veldhoven, the Netherlands, May 2016.
  72. Distrubution of lymph node metastases in esophageal adenocarcinoma after neoadjuvant chemoradiation therapy: a prospective cohort study. HT Kunzli, AS van Rijswijk, SL Meijer, ED Geijsen, MI van Berge Henegouwen, SS Gisbertz. DDW, San Diego, USA, May 2016.
  73. Esophageal cancer patients’ management: cross-cultural differences between Dutch and Italian patients in perceived quality of provided oncological information. Luca Saadeh, Annelijn Slaman, Eleonora Pinto, Suzanne S. Gisbertz, Francesco Cavallin, Egle Jezerskyte, Rita Alfieri, Maria Cristina Bellissimo, Matteo Cagol, Carlo Castoro, Marco Scarpa, Mark I. van Berge Henegouwen  DDW, San Diego, USA, May 2016.
  74. Perfusion Diagnostics with Optical Technologies in Gastric-tube Surgery. Making the invisible, visible. Jansen SM, de Bruin DM, van Berge Henegouwen MI, Veelo DP, van Leeuwen TG, Strackee SD, Gisbertz SS. MDRM Esophageal Cancer, Amsterdam, the Netherlands, April 2016.
  75. Perfusion of Tissue assessed with Optical Technologies. Jansen SM, de Bruin DM, van Berge Henegouwen MI, Veelo DP, Strackee SD, Gisbertz SS, van Leeuwen TG. COST – European cooperation in Science & Technology. Barcelona, Spain, March 2016.
  76. Feasibility of long course chemoradiotherapy plus surgery for patients with cT4b oesophageal carcinoma. MCJ Anderegg,  JP Ruurda, SS Gisbertz, MN Sosef, BPL Wijnhoven, MCCM Hulshof, JJGHM Bergman, HWM van Laarhoven, MI van Berge Henegouwen. NVGE, Veldhoven, the Netherlands, March 2016.
  77. Preoperative chemoradiotherapy versus perioperative chemotherapy for patients with resectable esophageal or gastroesophageal junction adenocarcinoma. M.C.J. Anderegg, P.C. van der Sluis, J.P. Ruurda, S.S. Gisbertz, M.C.C.M. Hulshof, M. Van Vulpen, N. Haj Mohammed, H.W.M. van Laarhoven, M.I. van Berge Henegouwen, R. van Hillegersberg. NVGE, Veldhoven, the Netherlands, March 2016.
  78. Improved anastomotic leakage rates in patients following Ivor Lewis esophagectomy with omental wrap and pleural flap. AE Slaman, JAH Gooszen, MI van Berge Henegouwen, SS Gisbertz. NVGE, Veldhoven, the Netherlands, March 2016.
  79. Distribution of lymph node metastases in esophageal adenocarcinoma after neoadjuvant chemoradiation therapy: a prospective cohort study. H Kunzli, AS van Rijswijk, ED Geijsen, SL Meijer, MI van Berge Henegouwen, SS Gisbertz. NVGE, Veldhoven, the Netherlands, March 2016.
  80. Prognosis in upper GI will be improved by better surgery. SS Gisbertz. 5D congress, Ermelo, February 2016 (invited speaker).
  81. Comparison of Perfusion Diagnostics with Optical Coherence Tomography, Sidestream Darkfield Microscopy, Incident Darkfield Microscopy and Laser Speckle Contrast Imaging in a Tissue-like Flow Phantom. Jansen SM, de Bruin DM, van Berge Henegouwen MI, Veelo DP, Strackee SD, Gisbertz SS, van Leeuwen TG. Advanced Biomedical and Clinical Diagnostic and Surgical Guidance Systems, SPIE PHOTONICS WEST, San Fransisco, USA, February 2016.
  82. The impact of the clinical stage, pathological stage and the effect of downstaging after neoadjuvant therapy in patients with cancer of the esophagus. AW Phillips, SM Lagarde, SS Gisbertz, B Disep, A Immanuel, MI van Berge Henegouwen, SM Griffin. ESDE, Stockholm, Sweden, November 2015.
  83. Ex-vivo lymph node dissection allows accurate lymph node mapping for prognostification in adenocarcinoma of the esophagus after neoadjuvant therapy. SM Lagarde, AW Phillips, SS Gisbertz, B Disep, A Immanuel, SM Griffin. ESDE, Stockholm, Sweden, November 2015.
  84. Techniques and short term outcomes for total minimally invasive Ivor Lewis esophageal resection in distal esophageal and gastro-esophageal junction cancers. Pooled data from 6 European centers. J Straatman, N van der Wielen, GAP Nieuwenhuijzen, C Rosman, J Roig, JJG Scheepers, MA Cuesta, MDP Luyer, MI van Berge Henegouwen, F van Workum, SS Gisbertz, DL van der Peet. ESDE, Stockholm, Sweden, November 2015.
  85. The prognostic impact of extracapsular lymph node involvement after neoadjuvant therapy and esophagectomy. SM Lagarde, M Navidi, J Sultan, SS Gisbertz, HWM van Laarhoven, SL Meijer, A Immanuel, MI van Berge Henegouwen, SM Griffin. ESDE, Stockholm, Sweden, November 2015.
  86. Distribution of lymph node metastases in esophageal adenocarcinoma: a prospective cohort study. HT Kunzli, AS van Rijswijk, SL Meijer, MI van Berge Henegouwen, SS Gisbertz. ESDE, Stockholm, Sweden, November 2015.
  87. Using the comprehensive complication index to asses the impact of neoadjuvant chemoradiotherapy on postoperative complications after esophagectomy for cancer. N Nederlof, AE Slaman, P van Hagen, A van der Gaast, K Slankamenac, SS Gisbertz, JJB van Lanschot, BPL Wijnhoven, MI van Berge Henegouwen. ESDE, Stockholm, Sweden, November 2015.
  88. Differences in oncologic esophageal surgery in terms of surgical approach and extent of lymphadenectomy. Findings of an international survey on the treatment of esophageal cancer. AS van Rijswijk, MI van Berge Henegouwen, DL van der Peet, SS Gisbertz. ESDE, Stockholm, Sweden, November 2015.
  89. Symptomatic diafragmatic hernia after esophageal surgery. JA Gooszen, AE Slaman, SS Gisbertz, MI van Berge Henegouwen. ESDE, Stockholm, Sweden, November 2015.
  90. Radiation dose on the future anastomotic region of the stomach does not influence anastomotic complications in patients treated with neoadjuvant chemoradiation and esophagectomy with a cervical anastomosis. M Koeter, M Hulshof, M van der Sangen, M Luyer, N Kathiravetpillai, MCJ Anderegg, JAH Gooszen, SS Gisbertz, MI van Berge Henegouwen, GAP Nieuwenhuijzen. ESDE, Stockholm, Sweden, November 2015.
  91. Improved anastomotic leakage rates in patients following Ivor Lewis esophagectomy with omental wrap and pleural flap. AS Slaman, MI van Berge Henegouwen, SS Gisbertz. ESDE, Stockholm, Sweden, November 2015.
  92. Feasibility of long-course chemoradiotherapy plus surgery for patients with cT4b esophageal carcinoma. MCJ Anderegg, JP Ruurda, SS Gisbertz, MN Sosef, BPL Wijnhoven, MCCM Hulshof, JJGHM Bergman, HWM van Laarhoven, MI van Berge Henegouwen. ESDE, Stockholm, Sweden, November 2015.
  93. Preoperative chemoraiotherapy versus perioperative chemotherapy for patients with resectable esophageal or gastro-esopahgeal junction adenocarcinoma. M.C.J. Anderegg, P.C. van der Sluis, J.P. Ruurda, S.S. Gisbertz, M.C.C.M. Hulshof, M. van Vulpen, N. Haj Mohammed, H.W.M. van Laarhoven, M.I. van Berge Henegouwen, R. van Hillegersberg. ESDE, Stockholm, Sweden, November 2015.
  94. Inclusion of the postoperative nodal status improves the prognostic accuracy of the tumour regression grade after neoadjuvant chemoradiotherapy and resection of oesophageal carcinoma. MCJ Anderegg, SM Lagarde, SS Gisbertz, WAA Borstlap, SL Meijer, MCCM Hulshof, JJGHM. Bergman, ORC Busch, HWM van Laarhoven, MI van Berge Henegouwen. ESDE, Stockholm, Sweden, November 2015.
  95. Metformin use during treatment of potentially curable esophageal cancer patients is not associated with better outcomes. Spierings LEAMM, Lagarde SM, van Oijen MGH, Gisbertz SS, Wilmink JW, Hulshof MCCM, Meijer SL, Anderegg MC, van Berge Henegouwen MI, van Laarhoven HWM. UEGW, Barcelona, Spain, October 24-28, 2015.
  96. Distribution of lymph node metastases in oesophageal adenocarcinoma; a prospective cohort study. Kunzli H, Rijswijk van AS, Berge Henegouwen van MI, Gisbertz SS. UEGW, Barcelona, Spain, October 24-28, 2015.
  97. The prognostic value of a modified tumor regression grade after neoadjuvant chemoradiotherapy and resection of esophageal carcinoma. Anderegg MCJ, Lagarde SM, Gisbertz SS, Borstlap WAA Meijer SL, Hulshof MCCM, Bergman JJGHM, Busch ORC, van Laarhoven HWM, van Berge Henegouwen MI. UEG Week, Barcelona, Spanje, 28 oktober 2015.
  98. De voorspellende waarde van een gemodificeerde tumor regressie score na neoadjuvante chemoradiotherapie gevolgd door een resectie van het oesofaguscarcinoom. Anderegg MCJ, Lagarde SM, Gisbertz SS, Borstlap WAA, Meijer SL, Hulshof MCCM, Bergman JJGHM, Busch ORC, van Laarhoven HWM, van Berge Henegouwen MI. NVGE Najaarscongres, Veldhoven, Nederland, 8 oktober 2015.
  99. Distribution of lymph node metastases in esophageal adenocarcinoma; a prospective cohort study. Rijswijk van AS, Kunzli H, Berge Henegouwen van MI, Gisbertz SS. OESO, Monaco, September 2015.
  100. The effect of intra-operative goal directed fluid therapy (GDFT) on outcome after esophageal surgery- a Quality Improvement Study. Denise P. Veelo, MD, PhD, Mark I. van Berge Henegouwen MD, PhD, Kirsten S. Ouwehand, MD, Bart F. Geerts, MD, PhD, Maarten C.J. Anderegg MD, Susan van Dieren, MD, PhD, Jan M. Binnekade, Msc, PhD, Suzanne S. Gisbertz, MD, PhD, Markus W. Hollmann, MD, PhD. Annual meeting of European Society of Anesthesiology June 2015, Berlin.
  101. Laparoscopic gastrectomy for gastric cancer: results of the implementation of a new technique. E.J.Jongerius, M.I. van Berge Henegouwen, S.M. Lagarde, S.S. Gisbertz. IGCC, Sao Paulo, Brazil, June 2015.
  102. Omentectomy in patients with gastric cancer [OMEGA trial]. EJ Jongerius, MS, D Boerma, MD, PhD, CA Seldenrijk, MD, PhD, SL Meijer, MD, PhD, JJG Scheepers MD, PhD, F Smedts, MD, PhD, MI van Berge Henegouwen, MD, PhD, SM Lagarde MD, PhD, O Balague Ponz, MD, PhD, JW van Sandick, MD, PhD, SS Gisbertz, MD, PhD. IGCC, Sao Paulo, Brazil, June 2015.
  103. Laparoscopic gastrectomy for gastric cancer. EJ Jongerius, MI van Berge Henegouwen, SS Gisbertz. IGCC, Sao Paulo, Brazil, June 2015.
  104. GE junction tumors. Invited video presentation. SS Gisbertz. IGCC, Sao Paulo, Brazil, June 2015 (invited speaker).
  105. De voorspellende waarde van een gemodificeerde tumor regressie score na neoadjuvante chemoradiotherapie gevolgd door een resectie van het oesofaguscarcinoom. M.C.J. Anderegg, S.M. Lagarde, W.A.A. Borstlap, S.S. Gisbertz, S.L. Meijer, M.C.C.M. Hulshof, J.J.G.H.M. Bergman, O.R.C. Busch, H.W.M. van Laarhoven, M.I. van Berge Henegouwen. Chirurgendagen, Veldhoven, Nederland, 28 mei 2015.
  106. De prognostische waarde van kapseldoorbraak na neoadjuvante therapie gevolgd door een slokdarmresectie. S.M. Lagarde, M. Navidi, J. Sultan, S.S. Gisbertz, S.L. Meijer, H.W.M. van Laarhoven, A. Immanuel, S.M. Griffin, M.I. van Berge Henegouwen. Chirurgendagen, Veldhoven, Nederland, 28 mei 2015.
  107. The prognostic impact of extracapsular lymph node involvement after neoadjuvant therapy and oesophagectomy. SM Lagarde, M Navidi, J Sultan, SS Gisbertz, HM van Laarhoven, SL Meijer, A Immanuel, MI van Berge Henegouwen, M Griffin. DDF meeting, London, UK, June 2015.
  108. The relevance of lymph node metastases in the proximal field of the chest in patients with adenocarcinoma of the gastro-oesophageal junction treated with neoadjuvant therapy followed by transthoracic oesophagectomy. SM Lagarde, VP Jagadesham, SS Gisbertz, A Immanuel, MI van Berge Henegouwen, M Griffin. DDF meeting, London, UK, June 2015.
  109. The prognostic value of a modified tumor regression grade after neoadjuvant chemoradiotherapy and resection of esophageal carcinoma. M.C.J. Anderegg, S.M. Lagarde, W.A.A. Borstlap, S.S. Gisbertz, S.L. Meijer, M.C.C.M. Hulshof, J.J.G.H.M. Bergman, O.R.C. Busch, H.W.M. van Laarhoven, M.I. van Berge Henegouwen. American Society of Clinical Oncology Annual meeting, Chicago, USA, May 2015.
  110. De voorspellende waarde van een gemodificeerde tumor regressie score na neoadjuvante chemoradiotherapie gevolgd door een resectie van het oesofaguscarcinoom. MCJ Anderegg, SM Lagarde, WAA Borstlap, SS Gisbertz, SL Meijer, MCCM Hulshof, JJGHM Bergman, ORC Busch, HWM van Laarhoven, MI van Berge Henegouwen. Chirurgendagen, Veldhoven, Nederland, May 2015.
  111. Laparoscopic gastrectomy for gastric cancer: results of implementation of a new technique. Jongerius EJ, Berge Henegouwen van MI, Lagarde SM, Gisbertz SS. NVvH, Utrecht, Nederland, November 2014.
  112. De ‘Comprehensive Complication Index’ geeft een beter beeld van de ernst van complicaties bij patiënten na een oesophagusresectie dan de Clavien-Dindo classificatie. AE Slaman, SM Lagarde, SS Gisbertz, MI van Berge Henegouwen. NVvH, Utrecht, Nederland, November 2014.
  113. Thoracolaparoscopic dissection of lymph nodes involved in the drainage of the esophagus is feasible and safe in human cadavers and swine. HT Künzli, MI van Berge Henegouwen, SS Gisbertz, MJ Wiezer, CA Seldenrijk, BL Weusten. NVvH, Utrecht, Nederland, November 2014.
  114. Behandelstrategieën van recidief oesophagus- en junctiecarcinomen. R Butter, SM Lagarde, MCJ Anderegg,  SS Gisbertz, SL Meijer, MC Hulshof, JJ Bergman, MI van Berge Henegouwen, HWM van Laarhoven. NVvH, Utrecht, Nederland, November 2014.
  115. Distribution of lymph node metastases in esophageal carcinoma: a systematic review. Borstlap WAA, Rijsdijk AS, Berge Henegouwen van MI, Lagarde SM, Gisbertz SS. UEGW, Wenen, Oostenrijk, Oktober 2014.
  116. Laparoscopic gastrectomy for gastric cancer: results of implementation of a new technique. Jongerius EJ, Berge Henegouwen van MI, Lagarde SM, Gisbertz SS. UEGW, Wenen, Oostenrijk, Oktober 2014.
  117. Omentectomy in Gastric Cancer; a prospective cohort trial. Jongerius EJ, Boerma D, Seldenrijk CA, Meijer SL, Scheepers JJG, Smedts F, Berge Henegouwen MI van, Balague Ponz O, Sandick JW van, Gisbertz SS. UEGW, Wenen, Oostenrijk, Oktober 2014.
  118. Tumor stroma ratio (TSR) in esophageal adenocarcinoma biopsies in the prediction of response to neoadjuvant therapy and overall survival. Hetterschijt CRM, Lagarde SM,. Blom RLGM, Anderegg MCJ, van Laarhoven HWM, Meijer SL, Gisbertz  SS, van Berge Henegouwen MI. UEGW, Wenen, Oostenrijk, Oktober 2014.
  119. The impact of lymph node metastasis near the celiac trunc in patients with cancer of the distal esophagus or gastro-esophageal junction. Lagarde SM, Anderegg MCJ, Gisbertz SS, Meijer SL, Hulshof MCCM, Bergman JJGHM, van Laarhoven HWM, van Berge Henegouwen MI. UEGW, Wenen, Oostenrijk, Oktober 2014.
  120. Survival after pathologic complete response in patients with cancer of the esophagus or gastro-esophageal junction. Lagarde SM, Anderegg MCJ, Borstlap WAA, Gisbertz SS, Meijer SL, Hulshof MCCM, Bergman JJGHM, van Laarhoven HWM, van Berge Henegouwen MI. UEGW, Wenen, Oostenrijk, Oktober 2014.
  121. The relevance of the location of involved nodes in patients with cancer of the distal esophagus or gastro-esophageal junction. Lagarde SM, Anderegg MCJ, Gisbertz SS, Meijer SL, Hulshof MCCM, Bergman JJGHM, van Laarhoven HWM, van Berge Henegouwen MI. UEGW, Wenen, Oostenrijk, Oktober 2014.
  122. Laparoscopic gastrectomy for gastric cancer. SS Gisbertz. NVGE, Veldhoven, Nederland, Oktober 2014 (invited speaker)
  123. Laparoscopic gastrectomy for gastric cancer: results of implementation of a new technique. Jongerius EJ, Berge Henegouwen van MI, Lagarde SM, Gisbertz SS. NVGE, Veldhoven, Nederland, Oktober 2014.
  124. Omentectomy in patients with gastric cancer. [OMEGA trial]. Jongerius EJ, Boerma D, Seldenrijk CA, Meijer SL, Scheepers JJG, Smedts F, Berge Henegouwen MI van, Balague Ponz O, Sandick JW van, Gisbertz SS. NVGE, Veldhoven, Nederland, Oktober 2014.
  125. Tumor stroma ratio (TSR) in esophageal adenocarcinoma biopsies in the prediction of response to neoadjuvant therapy and overall survival. Hetterschijt CRM, Lagarde SM,. Blom RLGM, Anderegg MCJ, van Laarhoven HWM, Meijer SL, Gisbertz  SS, van Berge Henegouwen MI. NVGE, Veldhoven, Nederland, Oktober 2014.
  126. The relevance of the location (including the celiac trunk region) of involved nodes in patients with cancer of the distal esophagus or gastro-esophageal junction. Lagarde SM, Anderegg MCJ, Gisbertz SS, Meijer SL, Hulshof MCCM, Bergman JJGHM, van Laarhoven HWM, van Berge Henegouwen MI. NVGE, Veldhoven, Nederland, Oktober 2014.
  127. The role of statins in the treatment of esophageal cancer patients. Anderegg MCJ, Lagarde SM,  Gisbertz SS, Meijer SL, Hulshof MCCM, Bergman JJGHM, van Laarhoven HWM, van Berge Henegouwen MI. NVGE, Veldhoven, Nederland, Oktober 2014.
  128. Survival after pathologic complete response in patients with cancer of the esophagus or gastro-esophageal junction. Lagarde SM, Anderegg MCJ, Borstlap WAA, Gisbertz SS, Meijer SL, Hulshof MCCM, Bergman JJGHM, van Laarhoven HWM, van Berge Henegouwen MI. NVGE, Veldhoven, Nederland, Oktober 2014
  129. Distribution of lymph node metastases in esophageal carcinoma: a systematic review. Borstlap WAA, Berge Henegouwen van MI, Lagarde SM, Gisbertz SS. ISDE, Vancouver, Canada, September 2014.
  130. Thoracolaparoscopic dissection of esophageal lymph nodes is feasible in human cadavers, and safe in a porcine survival study. Künzli H, van Berge Henegouwen MI, Gisbertz SS, Seldenrijk C, Kuijpers K, Hazebroek E, Lagarde SM, Meijer S, Bergman J, Wiezer MA, Weusten B. ISDE, Vancouver, Canada, September 2014.
  131. Quality of life after minimally invasive versus open esophagectomy: results of a randomized controlled trial. Donald Van Der Peet, Kirsten Maas, Mark Van Berge Henegouwen, Camiel Rosman, Joseph Roig, Suzanne Gisbertz, Surya Biere, Luigi Bonavina, Jennifer Straatman, Miguel Cuesta. ISDE, Vancouver, Canada, September 2014.
  132. A new concept of the anatomy of the thoracic oesophagus: the meso-oesophagus. Miguel Cuesta, Teus Weijs, Ronald Bleijs, Richard Van Hillegersberg, Babs Zonderhuis, Mark Van Berge Henegouwen, Suzanne Gisbertz, Joris Scheepers, Jelle Ruurda, Jennifer Straatman, Harushi Osugi, Donald Van Der Peet. ISDE, Vancouver, Canada, September 2014.
  133. European experience: technique and short- term outcome of minimally invasive ivor lewis esophageal resection for distal esophageal and gastro-esophageal junction cancers. Jennifer Straatman, Kirsten Maas, Joseph Roig, Miguel Cuesta, Suzanne Gisbertz, Camiel Rosman, Surya Biere, Donald Van Der Peet. ISDE, Vancouver, Canada, September 2014.
  134. The relevance of the location of involved nodes in patients with cancer of the distal esophagus or gastro-esophageal junction. Lagarde SM, Anderegg MCJ, Gisbertz SS, Meijer SL, Hulshof MCCM, Bergman JJGHM, van Laarhoven HWM, van Berge Henegouwen MI. ISDE, Vancouver, Canada, September 2014.
  135. Tumor stroma ratio (TSR) in esophageal adenocarcinoma biopsies in the prediction of response to neoadjuvant therapy and overall survival. Hetterschijt CRM, Lagarde SM,. Blom RLGM, Anderegg MCJ, van Laarhoven HWM, Meijer SL, Gisbertz  SS, van Berge Henegouwen MI. ISDE, Vancouver, Canada, September 2014.
  136. The impact of lymph node metastasis near the celiac trunk in patients with cancer of the distal esophagus or gastro-esophageal junction. Lagarde SM, Anderegg MCJ, Gisbertz SS, Meijer SL, Hulshof MCCM, Bergman JJGHM, van Laarhoven HWM, van Berge Henegouwen MI. ISDE, Vancouver, Canada, September 2014.
  137. The role of statines in the treatment of esophageal cancer patients. Anderegg MCJ, Lagarde SM,  Gisbertz SS, Meijer SL, Hulshof MCCM, Bergman JJGHM, van Laarhoven HWM, van Berge Henegouwen MI. ISDE, Vancouver, Canada, September 2014.
  138. Survival after pathologic complete response in patients with cancer of the esophagus or gastro-esophageal junction. Lagarde SM, Anderegg MCJ, Borstlap WAA, Gisbertz SS, Meijer SL, Hulshof MCCM, Bergman JJGHM, van Laarhoven HWM, van Berge Henegouwen MI. ISDE, Vancouver, Canada, September 2014.
  139. The precious trial: a step-up approach, CRP first followed by CT-scan imaging to ensure quality control after major abdominal surgery. Straatman J, Peet van der DL, Gisbertz SS, R. Holman, MA Cuesta. EAES, Paris, Frankrijk, Juni 2014.
  140. Minimally invasive approach after Chemo/Radio therapy. Cuesta MA, Gisbertz SS, Peet van der DL. EAES, Paris, Frankrijk, Juni 2014.
  141. Overleving bij patiënten met een slokdarm of maagcardia carcinoom en een complete pathologische respons na neoadjuvante chemo (radio) therapie. Lagarde SM, Anderegg MCJ, Borstlap WAA, Gisbertz SS, Meijer SL, Hulshof MCCM, Bergman JJGHM, van Laarhoven HWM, van Berge Henegouwen MI. Chirurgendagen, Veldhoven, Mei 2014.
  142. Is omentectomie bij radicale gastrectomie voor maagcarcinoom zinvol? Jongerius EJ, Boerma D, Seldenrijk CA, Meijer SL, Scheepers JJG, Smedts F, Berge Henegouwen MI van, Balague Ponz O, Sandick JW van, Gisbertz SS. Chirurgendagen, Veldhoven, Mei 2014.
  143. Thoracolaparoscopische oesophaguscardiaresectie met buismaagreconstructie en intrathoracale anastomose; een uitgebreide 2-velds lymfadenectomie. Gisbertz SS, Berge Henegouwen MI van, Lagarde SM. Chirurgendagen, Veldhoven, Mei 2014.
  144. Thoracolaparoscopic Dissection of Lymph Nodes Involved in the Drainage of the Esophagus Is Feasible and Safe in Human Cadavers and Swine. Hannah T. Künzli, Mark I. van Berge Henegouwen, Suzanne S. Gisbertz, Marinus J. Wiezer, Cees A. Seldenrijk, Jacques J. Bergman, Bas L. Weusten. DDW, Chicago, USA, Mei 2014.
  145. 18F-FDG PET-CT after neoadjuvant chemoradiotherapy in esophageal cancer patients to optimize surgical decision making. MCJ Anderegg, EJ de Groof, SS Gisbertz, RJ Bennink, SM Lagarde, JHG Klinkenbijl, SSKS Phoa, MGW Dijkgraaf, JJGHM Bergman, MCCM Hulshof, HWM van Laarhoven, MI van Berge Henegouwen. Congress of the European Society for Diseases of the Esophagus, Rotterdam, November 2013.
  146. 18F-FDG PET-CT after neoadjuvant chemoradiotherapy in esophageal cancer patients to optimize surgical decision making. MCJ Anderegg, EJ de Groof, SS Gisbertz, RJ Bennink, SM Lagarde, JHG Klinkenbijl, SSKS Phoa, MGW Dijkgraaf, JJGHM Bergman, MCCM Hulshof, HWM van Laarhoven, MI van Berge Henegouwen. United European Gastroenterology Week, Berlijn, Duitsland, Oktober 2013.
  147. 18F-FDG PET-CT after neoadjuvant chemoradiotherapy in esophageal cancer patients to optimize surgical decision making. MCJ Anderegg, EJ de Groof, SS Gisbertz, RJ Bennink, SM Lagarde, JHG Klinkenbijl, SSKS Phoa, MGW Dijkgraaf, JJGHM Bergman, MCCM Hulshof, HWM van Laarhoven, MI van Berge Henegouwen. Digestive Disease Week, Orlando, USA, Mei 2013.
  148. 18F-FDG PET-CT after neoadjuvant chemoradiotherapy in esophageal cancer patients to optimize surgical decision making. MCJ Anderegg, EJ de Groof, SS Gisbertz, RJ Bennink, SM Lagarde, JHG Klinkenbijl, SSKS Phoa, MGW Dijkgraaf, JJGHM Bergman, MCCM Hulshof, HWM van Laarhoven, MI van Berge Henegouwen. Chirurgendagen, Veldhoven, Mei 2013.
  149. 18F-FDG PET-CT after neoadjuvant chemoradiotherapy in esophageal cancer patients to optimize surgical decision making. MCJ Anderegg, EJ de Groof, SS Gisbertz, RJ Bennink, SM Lagarde, JHG Klinkenbijl, SSKS Phoa, MGW Dijkgraaf, JJGHM Bergman, MCCM Hulshof, HWM van Laarhoven, MI van Berge Henegouwen. NVGE Voorjaarsvergadering, Veldhoven, Maart 2013.
  150. Open versus minimaal invasieve resectie voor het oesophaguscarcinoom: de TIME trial. Biere SSYA, van Berge Henegouwen MI, Maas KW, Bonavina L, Rosman C, Roig Garcia J, Gisbertz SS, Klinkenbijl JHG, Hollmann MW, de Lange ESM, Bonjer HJ, van der Peet DL, Cuesta MA. Chirurgendagen, Veldhoven, Mei 2012.
  151. Visualisatie van de galwegen met Indocyanine Groen en een near-infrared camera tijdens laparoscopische cholecystectomie. Van Dam DA, Ankersmit M, van de Ven P, Gisbertz SS, Meijerink WJHM. Chirurgendagen, Veldhoven, Mei 2012.
  152. De laparoscopische hindernisbaan binnen de opleiding heelkunde. Gisbertz SS. WEC symposium. Chirurgendagen, Veldhoven, Mei 2012 (invited speaker).
  153. Extended lymphadenectomy in thoraco-laparoscopic esophagectomy: The Tokyo Experience. Gisbertz SS. Afsluitend congres NVGIC & NVCO, ‘s Hertogenbosch, December 2011 (invited speaker).
  154. Minimally invasive esophageal resection for cancer: a randomized controlled trial. Cuesta MA, Gisbertz SS, van Berge Henegouwen MI, Biere SSAY, Maas KW, van der Peet DL. ESE, New Castle, Engeland, November 2011.
  155. Thoracoscopic esophagectomy. Cuesta MA, Gisbertz SS, van der Peet DL. Innovation in Esophageal Surgery, Milaan, Italie, November 2011.
  156. Minimaal invasieve oesophagusresecties. Nu al de norm. Gisbertz SS. Workshop NVEC, Reykjavic, IJsland, Oktober 2011 (invited speaker)
  157. Remote endarterectomy for TASC D lesions of the SFA. Update of results including the Dutch REVAS trial. Gisbertz SS, de Vries JP. Najaarsvergadering Vaatdagen, Emmen, Oktober 2009 (invited speaker).
  158. Alcohol gebruik is geassocieerd met plaque phenotype en verminderd cardiovasculaire events in patiënten met perifeer vaatlijden, maar niet in patiënten met cerebrovasculair vaatlijden. Gisbertz SS, Derksen WJ, de Kleijn DP, Vink A, van der Graaf Y, Moll FL, Pasterkamp G, de Vries JP. Vaatdagen, Noordwijkerhout, April 2009.
  159. Remote Endarterectomy for Long-Segment Occlusions of the SFA; an Update of Technique and Results. de Vries JP, Gisbertz SS. 9th ICASVS, Bangkok, Oktober 2008.
  160. Remote Endarterectomy versus Supragenicular Bypass Surgery for Long Occlusions of the Superficial Femoral Artery. Short Term Results of a Multicenter Randomized Trial. Gisbertz SS, Tutein Nolthenius RP, van der Laan L, Overtoom TTh, Moll FL, de Vries JP. ESVS Congress, Nice, September 2008.
  161. Alcohol Use Reduces Cardiovascular Events in Patients with Peripheral Arterial Occlusive Disease, Possibly Due to Plaque Stabilisation. Gisbertz SS, Derksen WJ, Velema E, Hellings WE, de Kleijn DP, de Vries JP, Moll FL, Pasterkamp G. ESC Congress, München, September 2008.
  162. Longer Duration Of Peripheral Arterial Occlusive Disease Is Related To Higher Restenosis Rate After Endarterectomy Due To Constrictive Arterial Remodeling. Derksen WJM, Gisbertz SS, Vink A, Willemsen A, de Vries JPPM, Moll FL, Pasterkamp G. IVBM Congress, Sydney, Juni 2008.
  163. Botuline Toxine versus Isosorbidedinitraat in de Behandeling van Fissura Ani; een Prospectief Dubbel Blind Gerandomiseerde Trial. Festen S, Gisbertz SS, van Schaagen F, de Wit LT, van den Linden C, Gerhards MF. Chirurgendagen, Veldhoven, Mei 2008.
  164. De Trigger Trial: Een Gerandomiseerde Studie. Injectie met Depomedrol/Bupivacaïne of Klieven van de A0-pulley? Huiberts AA, Gisbertz SS, Vahl A, Heijden van der FH. Chirurgendagen, Veldhoven, Mei 2008.
  165. Remote Endarteriëctomie versus Supragenuale Bypass Chirurgie in de Behandeling van Lange Occlusies van de Arteria Femoralis Superficialis. Korte Termijn Resultaten van een Multicenter Gerandomiseerd Onderzoek. Gisbertz SS, Ramzan M, Tutein Nolthenius RP, van der Laan L, Moll FL. Vaatdagen, Noordwijk, April 2008.
  166. Infra-inguinal Atherosclerotic Plaque Characteristics are Independent Predictors of Major Systemic Cardiovascular Events. Derksen WJM, Gisbertz SS, Velema E, Hellings WE, de Kleijn DPV, Vink A, de Vries JPPM, Moll FL, Pasterkamp G. DAS congres, Ermelo, Maart 2008.
  167. Short-Term Results of Remote Endarterectomy versus Bypass Surgery for Long Occlusions of the SFA. A Randomized Trial. De Vries JPPM, Gisbertz SS, Tutein Nolthenius RP, Moll FL. Charing Cross, London, April 2007.
  168. Pijn rechtsonder in de buik bij vrouwen in de fertiele leeftijd: het diagnostisch traject naar de (on)juiste diagnose. Schreinemachers MC, Gisbertz SS, Marres GM, Simons MP, de Blok S, van Sandick JW. Najaarsvergadering, Ede, November 2004.
  169. Mannan-binding Lectin Plasma Levels Following Major Abdominal Surgery: a ‘Not So Acute’ Phase Protein. Van Till JWO, Boermeester MA, van Sandick  JW, Hart M, Gisbertz SS, Lamme B, van Lanschot JJB, Aarden LA. Surgical Infection Society, Como, Mei 2003.
  170. Behandeling van Perianale Fistels met Fibrinelijm. Gisbertz SS, Festen S, Sosef M, Gerhards MF. Chirurgendagen, Veldhoven, Mei 2003.
  171. Immune Responses and Prediction of Major Infection after Esophagectomy for Cancer. Van Sandick JW, Gisbertz SS, ten Berge IJM, van der Pouw Kraan TCTM, Out TA, Boermeester MA, van Lanschot JJB. United European Gastroenterology Week, Amsterdam, Oktober 2001.
  172. Relation Between Preoperative T cell Response Profile and Infectious Complication Risk in Patients Undergoing Transhiatal or Transthoracic Esophagectomy for Cancer. Van Sandick JW, Gisbertz SS, ten Berge IJM, van der Pouw Kraan TCTM, Out TA, Boermeester MA, van Lanschot JJB. AGA, Digestive Disease Week, San Diego, Mei 2000.
  173. Preoperative CD4+ and CD8+ T cell subsets and cytokine production in relation to prognosis in patients with adenocarcinoma of the oesophagus or oesophagogastric junction. Marja A. Boermeester, Johanna W. van Sandick, Suzanne S. Gisbertz, Tineke C. van der Pouw Kraan, Theo A. Out, Ineke J. ten Berge, Jan J. van Lanschot. Digestive Disease Week, San Diego, Mei 2000.
  174. Relation Between Preoperative T cell Response Profile and Infectious Complication Risk in Patients Undergoing Transhiatal or Transthoracic Esophagectomy for Cancer. Van Sandick JW, Gisbertz SS, ten Berge IJM, van der Pouw Kraan TCTM, Out TA, Boermeester MA, van Lanschot JJB. Ned. Ver. voor Gastroenterologie, Veldhoven, Maart 2000.